Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (54498)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Oct 7, 2015 (publication date) through Mar 31, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Mulak A, Bonaz B. Brain-gut-microbiota axis in Parkinson's disease. World J Gastroenterol 2015; 21(37): 10609-10620 [PMID: 26457021 DOI: 10.3748/wjg.v21.i37.10609] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i37/10609.htm |
| Number | Citing Articles |
| 1 |
Adrian L Lopresti. The Problem of Curcumin and Its Bioavailability: Could Its Gastrointestinal Influence Contribute to Its Overall Health-Enhancing Effects?. Advances in Nutrition 2018; 9(1): 41 doi: 10.1093/advances/nmx011
|
| 2 |
Rad Ghannadzadeh Kermani pour, Sara Kamali Zounouzi, Melina Farshbafnadi, Nima Rezaei. The interplay between gut microbiota composition and dementia. Reviews in the Neurosciences 2025; doi: 10.1515/revneuro-2024-0113
|
| 3 |
Morgane Linard, Alix Ravier, Louisa Mougué, Iris Grgurina, Anne‐Laurence Boutillier, Alexandra Foubert‐Samier, Frédéric Blanc, Catherine Helmer. Infectious Agents as Potential Drivers of α‐Synucleinopathies. Movement Disorders 2022; 37(3): 464 doi: 10.1002/mds.28925
|
| 4 |
Sara Gerhardt, M. Hasan Mohajeri. Changes of Colonic Bacterial Composition in Parkinson’s Disease and Other Neurodegenerative Diseases. Nutrients 2018; 10(6): 708 doi: 10.3390/nu10060708
|
| 5 |
Imanuel Lerman, Yifeng Bu, Rahul Singh, Harold A. Silverman, Anuj Bhardwaj, Alex J. Mann, Alik Widge, Joseph Palin, Christopher Puleo, Hubert Lim. Next generation bioelectronic medicine: making the case for non-invasive closed-loop autonomic neuromodulation. Bioelectronic Medicine 2025; 11(1) doi: 10.1186/s42234-024-00163-4
|
| 6 |
Surya Sudheer, Prateeksha Gangwar, Zeba Usmani, Minaxi Sharma, Vivek Kumar Sharma, Siva Sankar Sana, Fausto Almeida, Nawal Kishore Dubey, Dhananjaya Pratap Singh, Neeraj Dilbaghi, Hamid Reza Khayat Kashani, Vijai Kumar Gupta, Brahma Nand Singh, Maryam Khayatkashani, Seyed Mohammad Nabavi. Shaping the gut microbiota by bioactive phytochemicals: An emerging approach for the prevention and treatment of human diseases. Biochimie 2022; 193: 38 doi: 10.1016/j.biochi.2021.10.010
|
| 7 |
Mami Sato, Rieko Arakaki, Hiroaki Tawara, Takaaki Tsunematsu, Naozumi Ishimaru. Formation of Autoimmune Lesions Is Independent of Antibiotic Treatment in NOD Mice. International Journal of Molecular Sciences 2021; 22(6): 3239 doi: 10.3390/ijms22063239
|
| 8 |
Haitian Nan, Takahiro Natori, Yuta Ichinose, Kishin Koh, Yoshihisa Takiyama. Conjugal multiple system atrophy: Computing chance or investigating real patients?. Parkinsonism & Related Disorders 2020; 75: 122 doi: 10.1016/j.parkreldis.2020.03.005
|
| 9 |
Arianna Polverino, Pierpaolo Sorrentino, Matteo Pesoli, Laura Mandolesi. Nutrition and cognition across the lifetime: an overview on epigenetic mechanisms. AIMS Neuroscience 2021; 8(4): 448 doi: 10.3934/Neuroscience.2021024
|
| 10 |
Valeria D. Felice, Eamonn M. Quigley, Aideen M. Sullivan, Gerard W. O'Keeffe, Siobhain M. O'Mahony. Microbiota-gut-brain signalling in Parkinson's disease: Implications for non-motor symptoms. Parkinsonism & Related Disorders 2016; 27: 1 doi: 10.1016/j.parkreldis.2016.03.012
|
| 11 |
Taiwo G. Olubodun-Obadun, Ismail O. Ishola, Olufunmilayo O. Adeyemi. Impact of environmental toxicants exposure on gut-brain axis in Parkinson disease. Drug Metabolism and Personalized Therapy 2022; 37(4): 329 doi: 10.1515/dmpt-2021-0144
|
| 12 |
Gianfranco Natale, Larisa Ryskalin, Gabriele Morucci, Gloria Lazzeri, Alessandro Frati, Francesco Fornai. The Baseline Structure of the Enteric Nervous System and Its Role in Parkinson’s Disease. Life 2021; 11(8): 732 doi: 10.3390/life11080732
|
| 13 |
Hamed Mirzaei, Saman Sedighi, Ebrahim Kouchaki, Erfaneh Barati, Ehsan Dadgostar, Michael Aschner, Omid Reza Tamtaji. Probiotics and the Treatment of Parkinson's Disease: An Update. Cellular and Molecular Neurobiology 2022; 42(8): 2449 doi: 10.1007/s10571-021-01128-w
|
| 14 |
Shen-Yuan Zheng, Hai-Xia Li, Rui-Chen Xu, Wen-Teng Miao, Ming-Yuan Dai, Song-Tao Ding, Han-Deng Liu. Potential roles of gut microbiota and microbial metabolites in Parkinson’s disease. Ageing Research Reviews 2021; 69: 101347 doi: 10.1016/j.arr.2021.101347
|
| 15 |
James K. Ruffle, Steven J. Coen, Vincent Giampietro, Steven C.R. Williams, A. Vania Apkarian, Adam D. Farmer, Qasim Aziz. Morphology of subcortical brain nuclei is associated with autonomic function in healthy humans. Human Brain Mapping 2018; 39(1): 381 doi: 10.1002/hbm.23850
|
| 16 |
Ingar Olsen, Douglas B. Kell, Etheresia Pretorius. Is Porphyromonas gingivalis involved in Parkinson’s disease?. European Journal of Clinical Microbiology & Infectious Diseases 2020; 39(11): 2013 doi: 10.1007/s10096-020-03944-2
|
| 17 |
Eliseu da Cruz Moreira-Junior. Hyper-serotonergic state determines onset and progression of idiopathic Parkinson’s disease. Medical Hypotheses 2019; 133: 109399 doi: 10.1016/j.mehy.2019.109399
|
| 18 |
Steven P. Mathis, Sobha R. Bodduluri, Bodduluri Haribabu. Interrelationship between the 5-lipoxygenase pathway and microbial dysbiosis in the progression of Alzheimer's disease. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2021; 1866(9): 158982 doi: 10.1016/j.bbalip.2021.158982
|
| 19 |
Arun T Nair, Vadivelan Ramachandran, Nanjan M Joghee, Shanish Antony, Gopalakrishnan Ramalingam. Gut Microbiota Dysfunction as Reliable Non-invasive Early Diagnostic Biomarkers in the Pathophysiology of Parkinson's Disease: A Critical Review. Journal of Neurogastroenterology and Motility 2018; 24(1): 30 doi: 10.5056/jnm17105
|
| 20 |
Chunxiao Li, Li Cui, Yimin Yang, Jing Miao, Xiuzhen Zhao, Jingdian Zhang, Guohong Cui, Ying Zhang. Gut Microbiota Differs Between Parkinson’s Disease Patients and Healthy Controls in Northeast China. Frontiers in Molecular Neuroscience 2019; 12 doi: 10.3389/fnmol.2019.00171
|
| 21 |
Büin Adams, J. Massimo Nunes, Martin J. Page, Timothy Roberts, Jonathan Carr, Theo A. Nell, Douglas B. Kell, Etheresia Pretorius. Parkinson’s Disease: A Systemic Inflammatory Disease Accompanied by Bacterial Inflammagens. Frontiers in Aging Neuroscience 2019; 11 doi: 10.3389/fnagi.2019.00210
|
| 22 |
Anna D. Holmes, Julia Spoendlin, Anna L. Chien, Hilary Baldwin, Anne Lynn S. Chang. Evidence-based update on rosacea comorbidities and their common physiologic pathways. Journal of the American Academy of Dermatology 2018; 78(1): 156 doi: 10.1016/j.jaad.2017.07.055
|
| 23 |
Qingsen Shang, Ya Wang, Lin Pan, Qingfeng Niu, Chao Li, Hao Jiang, Chao Cai, Jiejie Hao, Guoyun Li, Guangli Yu. Dietary Polysaccharide from Enteromorpha Clathrata Modulates Gut Microbiota and Promotes the Growth of Akkermansia muciniphila, Bifidobacterium spp. and Lactobacillus spp.. Marine Drugs 2018; 16(5): 167 doi: 10.3390/md16050167
|
| 24 |
Jae-Hwan Jang, Mi-Jung Yeom, Sora Ahn, Ju-Young Oh, Suhwan Ji, Tae-Hong Kim, Hi-Joon Park. Acupuncture inhibits neuroinflammation and gut microbial dysbiosis in a mouse model of Parkinson’s disease. Brain, Behavior, and Immunity 2020; 89: 641 doi: 10.1016/j.bbi.2020.08.015
|
| 25 |
Guilian Yang, Yanlong Jiang, Wentao Yang, Fang Du, Yunbao Yao, Chunwei Shi, Chunfeng Wang. Effective treatment of hypertension by recombinant Lactobacillus plantarum expressing angiotensin converting enzyme inhibitory peptide. Microbial Cell Factories 2015; 14(1) doi: 10.1186/s12934-015-0394-2
|
| 26 |
Charul Rajput, Alika Sarkar, Nidhi Sachan, Neeraj Rawat, Mahendra Pratap Singh. Is Gut Dysbiosis an Epicenter of Parkinson’s Disease?. Neurochemical Research 2021; 46(3): 425 doi: 10.1007/s11064-020-03187-9
|
| 27 |
Sebastian Dohm-Hansen, Francisco Donoso, Paul J. Lucassen, Gerard Clarke, Yvonne M. Nolan. The gut microbiome and adult hippocampal neurogenesis: A new focal point for epilepsy?. Neurobiology of Disease 2022; 170: 105746 doi: 10.1016/j.nbd.2022.105746
|
| 28 |
Agnia Teterleva, Vladislav Abramov, Andrey Morgun, Irina Larionova, Michael Sadovsky. Bioinformatics and Biomedical Engineering. Lecture Notes in Computer Science 2022; 13346: 205 doi: 10.1007/978-3-031-07704-3_17
|
| 29 |
Monica Montagnani, Lucrezia Bottalico, Maria Assunta Potenza, Ioannis Alexandros Charitos, Skender Topi, Marica Colella, Luigi Santacroce. The Crosstalk between Gut Microbiota and Nervous System: A Bidirectional Interaction between Microorganisms and Metabolome. International Journal of Molecular Sciences 2023; 24(12): 10322 doi: 10.3390/ijms241210322
|
| 30 |
Claudio Nazzi, Alessio Avenanti, Simone Battaglia. The Involvement of Antioxidants in Cognitive Decline and Neurodegeneration: Mens Sana in Corpore Sano. Antioxidants 2024; 13(6): 701 doi: 10.3390/antiox13060701
|
| 31 |
Cristiana Vilela, Bruna Araújo, Carla Soares-Guedes, Rita Caridade-Silva, Joana Martins-Macedo, Catarina Teixeira, Eduardo D. Gomes, Cristina Prudêncio, Mónica Vieira, Fábio G. Teixeira. From the Gut to the Brain: Is Microbiota a New Paradigm in Parkinson’s Disease Treatment?. Cells 2024; 13(9): 770 doi: 10.3390/cells13090770
|
| 32 |
Alexandre Fisette, Domenico Sergi, Alyssa Breton-Morin, Savanah Descôteaux, Maria-Grazia Martinoli. New Insights on the Role of Bioactive Food Derivatives in Neurodegeneration and
Neuroprotection. Current Pharmaceutical Design 2022; 28(37): 3068 doi: 10.2174/1381612828666220919085742
|
| 33 |
Jialing Li, Danghan Xu, Yingyu Liu, Yang Cao, Jun He, Muxi Liao. Acupuncture Treatment of Guillain–Barré Syndrome After Using Immune Checkpoint Inhibitors: A Case Report. Frontiers in Neurology 2022; 13 doi: 10.3389/fneur.2022.908282
|
| 34 |
Samantha Molsberry, Kjetil Bjornevik, Katherine C. Hughes, Brian Healy, Michael Schwarzschild, Alberto Ascherio. Diet pattern and prodromal features of Parkinson disease. Neurology 2020; 95(15) doi: 10.1212/WNL.0000000000010523
|
| 35 |
L. A. Brsikyan, E. A. Poluektova, M. G. Poluektov. The gut microbiome as a factor in the development of Parkinson's disease. Neurology, Neuropsychiatry, Psychosomatics 2023; 15(1): 90 doi: 10.14412/2074-2711-2023-1-90-96
|
| 36 |
A. V. Stavrovskaya, V. N. Danilenko, D. N. Voronkov, A. S. Gushchina, M. V. Marsova, A. S. Olshansky, N. G. Yamshikova, S. N. Illarioshkin. Pharmabiotic Based on Lactobacillus fermentum Strain U-21 Modulates the Toxic Effect of 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine as Parkinsonism Inducer in Mice. Human Physiology 2021; 47(8): 891 doi: 10.1134/S0362119721080120
|
| 37 |
Garima Sharma, Monika Kadian, Kritika Sharma, Shivani Pandita, Kanishka Shrivasatava, Anil Kumar. Brain-Iron Cross Talk. Nutritional Neurosciences 2023; : 87 doi: 10.1007/978-981-19-7327-7_5
|
| 38 |
Mark H. Sundman, Nan-kuei Chen, Vignesh Subbian, Ying-hui Chou. The bidirectional gut-brain-microbiota axis as a potential nexus between traumatic brain injury, inflammation, and disease. Brain, Behavior, and Immunity 2017; 66: 31 doi: 10.1016/j.bbi.2017.05.009
|
| 39 |
Francisca Villavicencio-Tejo, Margrethe A. Olesen, Laura Navarro, Nancy Calisto, Cristian Iribarren, Katherine García, Gino Corsini, Rodrigo A. Quintanilla. Gut-Brain Axis Deregulation and Its Possible Contribution to Neurodegenerative Disorders. Neurotoxicity Research 2024; 42(1) doi: 10.1007/s12640-023-00681-0
|
| 40 |
Varruchi Sharma, Atul Sankhyan, Anshika Varshney, Renuka Choudhary, Anil K. Sharma. Current Paradigms to Explore the Gut Microbiota Linkage to Neurological Disorders. EMJ Neurology 2020; : 68 doi: 10.33590/emjneurol/20-00068
|
| 41 |
Angelica Varesi, Lucrezia Irene Maria Campagnoli, Foroogh Fahmideh, Elisa Pierella, Marcello Romeo, Giovanni Ricevuti, Marchesi Nicoletta, Salvatore Chirumbolo, Alessia Pascale. The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment. International Journal of Molecular Sciences 2022; 23(20): 12289 doi: 10.3390/ijms232012289
|
| 42 |
Eamonn M.M. Quigley. Basic Definitions and Concepts: Organization of the Gut Microbiome. Gastroenterology Clinics of North America 2017; 46(1): 1 doi: 10.1016/j.gtc.2016.09.002
|
| 43 |
Yanjun Shi, Lu Qin, Mengting Wu, Junyu Zheng, Tao Xie, Zhiyong Shao.
Gut neuroendocrine signaling regulates synaptic assembly in
C. elegans
. EMBO reports 2022; 23(8) doi: 10.15252/embr.202153267
|
| 44 |
Rijan Bajracharya, Neil A. Youngson, J. William O. Ballard. Dietary Macronutrient Management to Treat Mitochondrial Dysfunction in Parkinson’s Disease. International Journal of Molecular Sciences 2019; 20(8): 1850 doi: 10.3390/ijms20081850
|
| 45 |
Gabriele Deidda, Manuele Biazzo. Gut and Brain: Investigating Physiological and Pathological Interactions Between Microbiota and Brain to Gain New Therapeutic Avenues for Brain Diseases. Frontiers in Neuroscience 2021; 15 doi: 10.3389/fnins.2021.753915
|
| 46 |
Hui Wang, Feng Yang, Ruihua Xin, Dongan Cui, Jiongjie He, Shidong Zhang, Yan Sun. The gut microbiota attenuate neuroinflammation in manganese exposure by inhibiting cerebral NLRP3 inflammasome. Biomedicine & Pharmacotherapy 2020; 129: 110449 doi: 10.1016/j.biopha.2020.110449
|
| 47 |
Matthew C.L. Phillips, Deborah K.J. Murtagh, Linda J. Gilbertson, Fredrik J.S. Asztely, Christopher D.P. Lynch. Low‐fat versus ketogenic diet in Parkinson's disease: A pilot randomized controlled trial. Movement Disorders 2018; 33(8): 1306 doi: 10.1002/mds.27390
|
| 48 |
Tomislav Meštrović, Mario Matijašić, Mihaela Perić, Hana Čipčić Paljetak, Anja Barešić, Donatella Verbanac. The Role of Gut, Vaginal, and Urinary Microbiome in Urinary Tract Infections: From Bench to Bedside. Diagnostics 2020; 11(1): 7 doi: 10.3390/diagnostics11010007
|
| 49 |
M. Roy, M. Péré, P. Damier, S. Bruley des Varannes, P. Derkinderen, T. Rouaud. STW5 (Iberogast®) for constipation in Parkinson's disease. Revue Neurologique 2021; 177(3): 296 doi: 10.1016/j.neurol.2020.06.005
|
| 50 |
Hong-Xing Wang, Yu-Ping Wang. Gut Microbiota-brain Axis. Chinese Medical Journal 2016; 129(19): 2373 doi: 10.4103/0366-6999.190667
|
| 51 |
Subramanian Thangaleela, Bhagavathi Sundaram Sivamaruthi, Periyanaina Kesika, Muruganantham Bharathi, Chaiyavat Chaiyasut. Nasal Microbiota, Olfactory Health, Neurological Disorders and Aging—A Review. Microorganisms 2022; 10(7): 1405 doi: 10.3390/microorganisms10071405
|
| 52 |
Ji Eun Kim, Ki Chun Kwon, You Jeong Jin, Ayun Seol, Hee Jin Song, Yu Jeong Roh, Tae Ryeol Kim, Eun Seo Park, Gi Ho Park, Ji Won Park, Young Suk Jung, Joon Yong Cho, Dae Youn Hwang. Compositional changes in fecal microbiota in a new Parkinson's disease model: C57BL/6-Tg(NSE-haSyn) mice. Laboratory Animal Research 2023; 39(1) doi: 10.1186/s42826-023-00181-4
|
| 53 |
Genaro Gabriel Ortiz, Luis H. de, José A. Cruz-Serrano, Erandis D. Torres-Sánchez, Miriam A. Mora-Navarro, Daniela L. C. Delgado- Lara, Irma Gabriela Ortiz-Velázquez, Héctor González-Usigli, Oscar K. Bitzer-Quintero, Mario Mireles Ramírez. Eat, Learn, Remember. 2019; doi: 10.5772/intechopen.79493
|
| 54 |
Jing Sun, Fangyan Wang, Zongxin Ling, Xichong Yu, Wenqian Chen, Haixiao Li, Jiangtao Jin, Mengqi Pang, Huiqing Zhang, Junjie Yu, Jiaming Liu. Clostridium butyricum attenuates cerebral ischemia/reperfusion injury in diabetic mice via modulation of gut microbiota. Brain Research 2016; 1642: 180 doi: 10.1016/j.brainres.2016.03.042
|
| 55 |
Christine Tara Peterson. Dysfunction of the Microbiota-Gut-Brain Axis in Neurodegenerative Disease: The Promise of Therapeutic Modulation With Prebiotics, Medicinal Herbs, Probiotics, and Synbiotics. Journal of Evidence-Based Integrative Medicine 2020; 25: 2515690X2095722 doi: 10.1177/2515690X20957225
|
| 56 |
Adreesh Mukherjee, Atanu Biswas, Shyamal Kumar Das. Gut dysfunction in Parkinson's disease. World Journal of Gastroenterology 2016; 22(25): 5742-5752 doi: 10.3748/wjg.v22.i25.5742
|
| 57 |
E. Fernández-Espejo. Microorganisms associated with increased risk of Parkinson’s disease. Neurología (English Edition) 2023; 38(7): 495 doi: 10.1016/j.nrleng.2020.08.023
|
| 58 |
Lisa M. Smith, Louise C. Parr‐Brownlie. A neuroscience perspective of the gut theory of Parkinson's disease. European Journal of Neuroscience 2019; 49(6): 817 doi: 10.1111/ejn.13869
|
| 59 |
Adam Shute, Dominique G. Bihan, Ian A. Lewis, Yasmin Nasser. Metabolomics: The Key to Unraveling the Role of the Microbiome in Visceral Pain Neurotransmission. Frontiers in Neuroscience 2022; 16 doi: 10.3389/fnins.2022.917197
|
| 60 |
Yogesh Bhattarai, Purna C. Kashyap. Parkinson’s disease: Are gut microbes involved?. American Journal of Physiology-Gastrointestinal and Liver Physiology 2020; 319(5): G529 doi: 10.1152/ajpgi.00058.2020
|
| 61 |
Mengting Luan, Jianing Jin, Ying Wang, Xiaoyuan Li, Anmu Xie. Association of PGLYRP2 gene polymorphism and sporadic Parkinson's disease in northern Chinese Han population. Neuroscience Letters 2022; 775: 136547 doi: 10.1016/j.neulet.2022.136547
|
| 62 |
Ling-Xiao Yi, Eng King Tan, Zhi Dong Zhou. The α-Synuclein Seeding Amplification Assay for Parkinson’s Disease. International Journal of Molecular Sciences 2025; 26(1): 389 doi: 10.3390/ijms26010389
|
| 63 |
Melissa Scholefield, Stephanie J. Church, Jingshu Xu, Stefano Patassini, Nigel M. Hooper, Richard D. Unwin, Garth J. S. Cooper. Substantively Lowered Levels of Pantothenic Acid (Vitamin B5) in Several Regions of the Human Brain in Parkinson’s Disease Dementia. Metabolites 2021; 11(9): 569 doi: 10.3390/metabo11090569
|
| 64 |
Fang Li, Peng Wang, Zhu Chen, Xiafei Sui, Xinyu Xie, Jinbiao Zhang. Alteration of the fecal microbiota in North-Eastern Han Chinese population with sporadic Parkinson’s disease. Neuroscience Letters 2019; 707: 134297 doi: 10.1016/j.neulet.2019.134297
|
| 65 |
Edward Lu, Sumit Sarkar, James Raymick, Merle G. Paule, Qiang Gu. Decreased Mcl-1 protein level in the striatum of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice. Brain Research 2018; 1678: 432 doi: 10.1016/j.brainres.2017.11.014
|
| 66 |
Ali Keshavarzian, Phillip Engen, Salvatore Bonvegna, Roberto Cilia. Recent Advances in Parkinson's Disease. Progress in Brain Research 2020; 252: 357 doi: 10.1016/bs.pbr.2020.01.004
|
| 67 |
Alexandra Cosma-Grigorov, Holger Meixner, Anne Mrochen, Stefan Wirtz, Jürgen Winkler, Franz Marxreiter. Changes in Gastrointestinal Microbiome Composition in PD: A Pivotal Role of Covariates. Frontiers in Neurology 2020; 11 doi: 10.3389/fneur.2020.01041
|
| 68 |
María Elena Gómez-Gómez, Sara C. Zapico. Frailty, Cognitive Decline, Neurodegenerative Diseases and Nutrition Interventions. International Journal of Molecular Sciences 2019; 20(11): 2842 doi: 10.3390/ijms20112842
|
| 69 |
Shobha Kumari, Rajeev Taliyan, Sunil Kumar Dubey. Comprehensive Review on Potential Signaling Pathways Involving the Transfer of α-Synuclein from the Gut to the Brain That Leads to Parkinson’s Disease. ACS Chemical Neuroscience 2023; 14(4): 590 doi: 10.1021/acschemneuro.2c00730
|
| 70 |
Santosh Kumar Behera, Ardhendu Bhusan Praharaj, Gayathri Chalikonda, Gowru Srivani, Namita Mahapatra. Theranostics Approaches to Gastric and Colon Cancer. Diagnostics and Therapeutic Advances in GI Malignancies 2020; : 167 doi: 10.1007/978-981-15-2017-4_11
|
| 71 |
Claudia Vuotto, Luca Battistini, Carlo Caltagirone, Giovanna Borsellino. Gut Microbiota and Disorders of the Central Nervous System. The Neuroscientist 2020; 26(5-6): 487 doi: 10.1177/1073858420918826
|
| 72 |
Ye Tao, Sean X. Leng, Haiyan Zhang. Ketogenic Diet: An Effective Treatment Approach for Neurodegenerative
Diseases. Current Neuropharmacology 2022; 20(12): 2303 doi: 10.2174/1570159X20666220830102628
|
| 73 |
A. S. Baumuratov, P. M. A. Antony, M. Ostaszewski, F. He, L. Salamanca, L. Antunes, J. Weber, L. Longhino, P. Derkinderen, W. J. H. Koopman, N. J. Diederich. Enteric neurons from Parkinson’s disease patients display ex vivo aberrations in mitochondrial structure. Scientific Reports 2016; 6(1) doi: 10.1038/srep33117
|
| 74 |
Devina Chetty, Shameemah Abrahams, Riaan van Coller, Jonathan Carr, Colin Kenyon, Soraya Bardien. Movement of prion‐like α‐synuclein along the gut–brain axis in Parkinson's disease: A potential target of curcumin treatment. European Journal of Neuroscience 2021; 54(2): 4695 doi: 10.1111/ejn.15324
|
| 75 |
Wei Li, Xiaoli Wu, Xu Hu, Tao Wang, Shan Liang, Yunfeng Duan, Feng Jin, Bin Qin. Structural changes of gut microbiota in Parkinson’s disease and its correlation with clinical features. Science China Life Sciences 2017; 60(11): 1223 doi: 10.1007/s11427-016-9001-4
|
| 76 |
Fanny M. Elahi, Bruce L. Miller. A clinicopathological approach to the diagnosis of dementia. Nature Reviews Neurology 2017; 13(8): 457 doi: 10.1038/nrneurol.2017.96
|
| 77 |
Claudia Luna-Herrera, Irma A. Martínez-Dávila, Luis O. Soto-Rojas, Yazmin M. Flores-Martinez, Manuel A. Fernandez-Parrilla, Jose Ayala-Davila, Bertha A. León-Chavez, Guadalupe Soto-Rodriguez, Victor M. Blanco-Alvarez, Francisco E. Lopez-Salas, Maria E. Gutierrez-Castillo, Bismark Gatica-Garcia, America Padilla-Viveros, Cecilia Bañuelos, David Reyes-Corona, Armando J. Espadas-Alvarez, Linda Garcés-Ramírez, Oriana Hidalgo-Alegria, Fidel De La Cruz-lópez, Daniel Martinez-Fong, Fabiano Carvalho. Intranigral Administration of β-Sitosterol-β-D-Glucoside Elicits Neurotoxic A1 Astrocyte Reactivity and Chronic Neuroinflammation in the Rat Substantia Nigra. Journal of Immunology Research 2020; 2020: 1 doi: 10.1155/2020/5907591
|
| 78 |
Carl E. Cerniglia. Handbook of Developmental Neurotoxicology. 2018; : 265 doi: 10.1016/B978-0-12-809405-1.00023-7
|
| 79 |
Natasa Kustrimovic, Franca Marino, Marco Cosentino. Peripheral Immunity, Immunoaging and Neuroinflammation in Parkinson’s Disease. Current Medicinal Chemistry 2019; 26(20): 3719 doi: 10.2174/0929867325666181009161048
|
| 80 |
Sudhir K Dutta, Sandeep Verma, Vardhmaan Jain, Balarama K Surapaneni, Rakesh Vinayek, Laila Phillips, Padmanabhan P Nair. Parkinson’s Disease: The Emerging Role of Gut Dysbiosis, Antibiotics, Probiotics, and Fecal Microbiota Transplantation. Journal of Neurogastroenterology and Motility 2019; 25(3): 363 doi: 10.5056/jnm19044
|
| 81 |
Itsuka Kamimura, Ryou Kaneko, Hidetoshi Morita, Kazutaka Mogi, Takefumi Kikusui. Microbial colonization history modulates anxiety-like and complex social behavior in mice. Neuroscience Research 2021; 168: 64 doi: 10.1016/j.neures.2020.01.001
|
| 82 |
Xinrong Liu, Shuya Liu, Yong Tang, Zhengjia Pu, Hong Xiao, Jieying Gao, Qi Yin, Yan Jia, Qunhua Bai. Intragastric Administration of Casein Leads to Nigrostriatal Disease Progressed Accompanied with Persistent Nigrostriatal—Intestinal Inflammation Activited and Intestinal Microbiota—Metabolic Disorders Induced in MPTP Mouse Model of Parkinson’s Disease. Neurochemical Research 2021; 46(6): 1514 doi: 10.1007/s11064-021-03293-2
|
| 83 |
Michele Zuppi, Heather L. Hendrickson, Justin M. O’Sullivan, Tommi Vatanen. Phages in the Gut Ecosystem. Frontiers in Cellular and Infection Microbiology 2022; 11 doi: 10.3389/fcimb.2021.822562
|
| 84 |
Xuelun Zou, Leiyun Wang, Linxiao Xiao, Sai Wang, Le Zhang. Gut microbes in cerebrovascular diseases: Gut flora imbalance, potential impact mechanisms and promising treatment strategies. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.975921
|
| 85 |
TINGTING LIU, DINGYOU GUO, JIANSHE WEI. The pathogenesis of Parkinson’s disease and crosstalk with other diseases. BIOCELL 2024; 48(8): 1155 doi: 10.32604/biocell.2024.051518
|
| 86 |
Xianyi Lin, Yeru Chen, Piao Zhang, Gang Chen, Youfa Zhou, Xin Yu. The potential mechanism of postoperative cognitive dysfunction in older people. Experimental Gerontology 2020; 130: 110791 doi: 10.1016/j.exger.2019.110791
|
| 87 |
Cen Guo, Ya-Jing Huo, Yu Li, Yan Han, Da Zhou. Gut-brain axis: Focus on gut metabolites short-chain fatty acids. World Journal of Clinical Cases 2022; 10(6): 1754-1763 doi: 10.12998/wjcc.v10.i6.1754
|
| 88 |
Junze Geng, Can Liu, Jingyu Xu, Xiaoge Wang, Xinmin Li. Potential relationship between Tourette syndrome and gut microbiome. Jornal de Pediatria 2023; 99(1): 11 doi: 10.1016/j.jped.2022.06.002
|
| 89 |
Cecilia Binda, Loris Riccardo Lopetuso, Gianenrico Rizzatti, Giulia Gibiino, Vincenzo Cennamo, Antonio Gasbarrini. Actinobacteria: A relevant minority for the maintenance of gut homeostasis. Digestive and Liver Disease 2018; 50(5): 421 doi: 10.1016/j.dld.2018.02.012
|
| 90 |
Adil Ghafoor, Sahaana Sundar, Tennekoon Karunaratne, Satish S.C. Rao, Amol Sharma. Handbook of Gastrointestinal Motility and Disorders of Gut-Brain Interactions. 2023; : 345 doi: 10.1016/B978-0-443-13911-6.00028-1
|
| 91 |
Souvik Dubey, Ritwik Ghosh, Mahua Jana Dubey, Samya Sengupta, Shambaditya Das. From allegory to conceptualization, hypothesis and finally evidences: Alzheimer’s dementia, Parkinson's disease "gut–brain axis" and their preclinical phenotype. The Egyptian Journal of Neurology, Psychiatry and Neurosurgery 2024; 60(1) doi: 10.1186/s41983-024-00863-3
|
| 92 |
Lifan Zhong, Benchi Cai, Qitong Wang, Xi Li, Wendi Xu, Tao Chen. Exploring the Neuroprotective Mechanism of Curcumin Inhibition of Intestinal Inflammation against Parkinson’s Disease Based on the Gut-Brain Axis. Pharmaceuticals 2022; 16(1): 39 doi: 10.3390/ph16010039
|
| 93 |
Claudio Franceschi, Paolo Garagnani, Cristina Morsiani, Maria Conte, Aurelia Santoro, Andrea Grignolio, Daniela Monti, Miriam Capri, Stefano Salvioli. The Continuum of Aging and Age-Related Diseases: Common Mechanisms but Different Rates. Frontiers in Medicine 2018; 5 doi: 10.3389/fmed.2018.00061
|
| 94 |
Yu-Hang Li, Zhong-Xin Jiang, Qian Xu, Ting-Ting Jin, Jin-Fang Huang, Xiao Luan, Chong Li, Xin-Yi Chen, Ka-Hing Wong, Xiao-Li Dong, Xiang-Rong Sun. Inhibition of calcium-sensing receptor by its antagonist promotes gastrointestinal motility in a Parkinson’s disease mouse model. Biomedicine & Pharmacotherapy 2024; 174: 116518 doi: 10.1016/j.biopha.2024.116518
|
| 95 |
Rafael Franco, Irene Reyes-Resina, Gemma Navarro. Dopamine in Health and Disease: Much More Than a Neurotransmitter. Biomedicines 2021; 9(2): 109 doi: 10.3390/biomedicines9020109
|
| 96 |
Fabrizio Stocchi, Margherita Torti. Nonmotor Parkinson’s: The Hidden Face - Management and the Hidden Face of Related Disorders. International Review of Neurobiology 2017; 134: 811 doi: 10.1016/bs.irn.2017.06.003
|
| 97 |
Sreyashi Chandra, Md. Tanjim Alam, Jhilik Dey, Baby C. Pulikkaparambil Sasidharan, Upasana Ray, Amit K. Srivastava, Sonu Gandhi, Prem P. Tripathi. Healthy Gut, Healthy Brain: The Gut Microbiome in Neurodegenerative Disorders. Current Topics in Medicinal Chemistry 2020; 20(13): 1142 doi: 10.2174/1568026620666200413091101
|
| 98 |
O. Skillington, S. Mills, A. Gupta, E.A. Mayer, C.I.R. Gill, D. Del Rio, K.J. O’Riordan, J.F. Cryan, R.P. Ross, C. Stanton. The contrasting human gut microbiota in early and late life and implications for host health and disease. Nutrition and Healthy Aging 2021; 6(3): 157 doi: 10.3233/NHA-210129
|
| 99 |
Gouxin Huang, Raees Khan, Yilin Zheng, Ping-Chin Lee, Qingnan Li, Imran Khan. Exploring the role of gut microbiota in advancing personalized medicine. Frontiers in Microbiology 2023; 14 doi: 10.3389/fmicb.2023.1274925
|
| 100 |
Mengyu Hong, Chi‐Tang Ho, Xin Zhang, Ruilin Zhang, Yanan Liu. Dietary strategies may influence human nerves and emotions by regulating intestinal microbiota: an interesting hypothesis. International Journal of Food Science & Technology 2021; 56(7): 3311 doi: 10.1111/ijfs.14986
|
| 101 |
Mauro Giuffrè, Rita Moretti, Giuseppina Campisciano, Alexandre Barcelos Morais da Silveira, Vincenzo Maria Monda, Manola Comar, Stefano Di Bella, Roberta Maria Antonello, Roberto Luzzati, Lory Saveria Crocè. You Talking to Me? Says the Enteric Nervous System (ENS) to the Microbe. How Intestinal Microbes Interact with the ENS. Journal of Clinical Medicine 2020; 9(11): 3705 doi: 10.3390/jcm9113705
|
| 102 |
Rafael Franco, Berta Casanovas, Jordi Camps, Gemma Navarro, Eva Martínez-Pinilla. Antioxidant Supplements versus Health Benefits of Brief/Intermittent Exposure to Potentially Toxic Physical or Chemical Agents. Current Issues in Molecular Biology 2021; 43(2): 650 doi: 10.3390/cimb43020047
|
| 103 |
J. Massimo Nunes, Tristan Fillis, Martin J. Page, Chantelle Venter, Ophélie Lancry, Douglas B. Kell, Ursula Windberger, Etheresia Pretorius. Gingipain R1 and Lipopolysaccharide From Porphyromonas gingivalis Have Major Effects on Blood Clot Morphology and Mechanics. Frontiers in Immunology 2020; 11 doi: 10.3389/fimmu.2020.01551
|
| 104 |
Gitanjali P Panigrahi, Ankita R Rane, Sirisha L Vavilala, Sinjan Choudhary. Deciphering the anti-Parkinson’s activity of sulphated polysaccharides from Chlamydomonas reinhardtii on the α-Synuclein mutants A30P, A53T, E46K, E57K and E35K. The Journal of Biochemistry 2019; 166(6): 463 doi: 10.1093/jb/mvz064
|
| 105 |
Guixuan Wang, Danyang Zou, Xinying Lu, Xin Gu, Yuanyuan Cheng, Tengfei Qi, Yanchun Cheng, Junjun Yu, Meiping Ye, Pingyu Zhou. Gut Microbiota Alternation in Disease Progression of Neurosyphilis. Infection and Drug Resistance 2022; : 6603 doi: 10.2147/IDR.S389155
|
| 106 |
Rohan Gupta, Smita Kumari, Anusha Senapati, Rashmi K. Ambasta, Pravir Kumar. New era of artificial intelligence and machine learning-based detection, diagnosis, and therapeutics in Parkinson’s disease. Ageing Research Reviews 2023; 90: 102013 doi: 10.1016/j.arr.2023.102013
|
| 107 |
Alma Rosa Lezama Toledo, Germán Rivera Monroy, Felipe Esparza Salazar, Jea-Young Lee, Shalini Jain, Hariom Yadav, Cesario Venturina Borlongan. Gut–Brain Axis as a Pathological and Therapeutic Target for Neurodegenerative Disorders. International Journal of Molecular Sciences 2022; 23(3): 1184 doi: 10.3390/ijms23031184
|
| 108 |
David M. James, Elizabeth A. Davidson, Julio Yanes, Baharak Moshiree, Julia E. Dallman. The Gut-Brain-Microbiome Axis and Its Link to Autism: Emerging Insights and the Potential of Zebrafish Models. Frontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.662916
|
| 109 |
Li Xie, Dongmei Chen, Xinghui Zhu, Cisong Cheng. Efficacy and safety of probiotics in Parkinson’s constipation: A systematic review and meta-analysis. Frontiers in Pharmacology 2023; 13 doi: 10.3389/fphar.2022.1007654
|
| 110 |
N. Gorlé, C. Blaecher, E. Bauwens, C. Vandendriessche, S. Balusu, J. Vandewalle, C. Van Cauwenberghe, E. Van Wonterghem, G. Van Imschoot, C. Liu, R. Ducatelle, C. Libert, F. Haesebrouck, A. Smet, R.E. Vandenbroucke. The choroid plexus epithelium as a novel player in the stomach-brain axis during Helicobacter infection. Brain, Behavior, and Immunity 2018; 69: 35 doi: 10.1016/j.bbi.2017.12.010
|
| 111 |
Guillaume Blivet, Johann Meunier, Francois J. Roman, Jacques Touchon. Neuroprotective effect of a new photobiomodulation technique against Aβ25–35 peptide–induced toxicity in mice: Novel hypothesis for therapeutic approach of Alzheimer's disease suggested. Alzheimer's & Dementia: Translational Research & Clinical Interventions 2018; 4(1): 54 doi: 10.1016/j.trci.2017.12.003
|
| 112 |
Federica Del Chierico, Paola Grassini, Andrea Quagliariello, Margherita Torti, Alessandra Russo, Sofia Reddel, Fabrizio Stocchi. The Impact of Intestinal Microbiota on Weight Loss in Parkinson’s Disease Patients: A Pilot Study. Future Microbiology 2020; 15(14): 1393 doi: 10.2217/fmb-2019-0336
|
| 113 |
Shanti Diwakarla, Rachel M. McQuade, Remy Constable, Olivia Artaiz, Enie Lei, Kevin J. Barnham, Paul A. Adlard, Robert A. Cherny, Madeleine R. Di Natale, Hongyi Wu, Xin-yi Chai, Victoria A. Lawson, David I. Finkelstein, John B. Furness. ATH434 Reverses Colorectal Dysfunction in the A53T Mouse Model of Parkinson’s Disease. Journal of Parkinson's Disease 2021; 11(4): 1821 doi: 10.3233/JPD-212731
|
| 114 |
A. Prysiazhniuk, T. Dovbynchuk, B. Kopiyak, G. Tolstanova. The role of central and peripheral D2R receptors in the mechanism of colonic vascular permeability during experimental colitis in rats. Bulletin of Taras Shevchenko National University of Kyiv. Series: Problems of Physiological Functions Regulation 2017; 22(1): 39 doi: 10.17721/2616_6410.2017.22.39-43
|
| 115 |
Jade E. Kenna, Megan C. Bakeberg, Maddison Y. Abonnel, Frank L. Mastaglia, Ryan S. Anderton, Carlo Colosimo. Impact of Gastrointestinal Symptoms on Health-Related Quality of Life in an Australian Parkinson’s Disease Cohort. Parkinson's Disease 2022; 2022: 1 doi: 10.1155/2022/4053665
|
| 116 |
Tianfang Jiang, Gen Li, Jun Xu, Shane Gao, Xu Chen. The Challenge of the Pathogenesis of Parkinson's Disease: Is Autoimmunity the Culprit?. Frontiers in Immunology 2018; 9 doi: 10.3389/fimmu.2018.02047
|
| 117 |
Saurav Sarkar, Samapika Routhray, Balamurugan Ramadass, Pradipta Kumar Parida. A Review on the Nasal Microbiome and Various Disease Conditions for Newer Approaches to Treatments. Indian Journal of Otolaryngology and Head & Neck Surgery 2023; 75(S1): 755 doi: 10.1007/s12070-022-03205-y
|
| 118 |
Mohammad Rafi Khezri, Ayda Esmaeili, Morteza Ghasemnejad-Berenji. Role of Bmal1 and Gut Microbiota in Alzheimer’s Disease and Parkinson’s Disease Pathophysiology: The Probable Effect of Melatonin on Their Association. ACS Chemical Neuroscience 2023; 14(21): 3883 doi: 10.1021/acschemneuro.3c00418
|
| 119 |
Solène Pradeloux, Katherine Coulombe, Alexandre Jules Kennang Ouamba, Amandine Isenbrandt, Frédéric Calon, Denis Roy, Denis Soulet. Oral Trehalose Intake Modulates the Microbiota–Gut–Brain Axis and Is Neuroprotective in a Synucleinopathy Mouse Model. Nutrients 2024; 16(19): 3309 doi: 10.3390/nu16193309
|
| 120 |
Giuseppe Grosso, Justyna Godos, Fabio Galvano, Edward L. Giovannucci. Coffee, Caffeine, and Health Outcomes: An Umbrella Review. Annual Review of Nutrition 2017; 37(1): 131 doi: 10.1146/annurev-nutr-071816-064941
|
| 121 |
Ashwin Rajeev, Indranil Chattopadhyay. Gut Microbiome and Brain Ageing. 2024; : 261 doi: 10.1007/978-981-99-8803-7_13
|
| 122 |
Shokufeh Ghasemian Sorboni, Hanieh Shakeri Moghaddam, Reza Jafarzadeh-Esfehani, Saman Soleimanpour. A Comprehensive Review on the Role of the Gut Microbiome in Human Neurological Disorders. Clinical Microbiology Reviews 2022; 35(1) doi: 10.1128/CMR.00338-20
|
| 123 |
Eric L. Brown, Heather T. Essigmann, Kristi L. Hoffman, Ashley S. Alexander, Michael Newmark, Zhi-Dong Jiang, Jessika Suescun, Mya C. Schiess, Craig L. Hanis, Herbert L. DuPont. IgA-Biome Profiles Correlate with Clinical Parkinson’s Disease Subtypes. Journal of Parkinson’s Disease 2023; 13(4): 501 doi: 10.3233/JPD-230066
|
| 124 |
Vagdevi Hangarakatte Ramachandra, Senthilkumar Sivanesan, Anand Koppal, Shanmugam Anandakumar, Matthew D. Howell, Ethirajan Sukumar, Rajagopalan Vijayaraghavan. Embelin and levodopa combination therapy for improved Parkinson’s disease treatment. Translational Neuroscience 2022; 13(1): 145 doi: 10.1515/tnsci-2022-0224
|
| 125 |
Simon Isaiah, Du Toit Loots, Regan Solomons, Martijn van der Kuip, A. Marceline Tutu Van Furth, Shayne Mason. Overview of Brain-to-Gut Axis Exposed to Chronic CNS Bacterial Infection(s) and a Predictive Urinary Metabolic Profile of a Brain Infected by Mycobacterium tuberculosis. Frontiers in Neuroscience 2020; 14 doi: 10.3389/fnins.2020.00296
|
| 126 |
Rashad Alkasir, Jing Li, Xudong Li, Miao Jin, Baoli Zhu. Human gut microbiota: the links with dementia development. Protein & Cell 2017; 8(2): 90 doi: 10.1007/s13238-016-0338-6
|
| 127 |
Sumel Ashique, Sourav Mohanto, Mohammed Gulzar Ahmed, Neeraj Mishra, Ashish Garg, Dinesh Kumar Chellappan, Timothy Omara, Shabnoor Iqbal, Ivan Kahwa. Gut-brain axis: A cutting-edge approach to target neurological disorders and potential synbiotic application. Heliyon 2024; 10(13): e34092 doi: 10.1016/j.heliyon.2024.e34092
|
| 128 |
Marco Sancandi, Carmen De Caro, Neringa Cypaite, Nadia Marascio, Carmen Avagliano, Carmela De Marco, Emilio Russo, Andrew Constanti, Audrey Mercer. Effects of a probiotic suspension Symprove™ on a rat early-stage Parkinson’s disease model. Frontiers in Aging Neuroscience 2023; 14 doi: 10.3389/fnagi.2022.986127
|
| 129 |
Zhe Li, Hongfeng Liang, Yingyu Hu, Lin Lu, Chunye Zheng, Yuzhen Fan, Bin Wu, Tao Zou, Xiaodong Luo, Xinchun Zhang, Yan Zeng, Ziyan Liu, Zhicheng Zhou, Zhenyu Yue, Yi Ren, Zhuo Li, Qiaozhen Su, Pingyi Xu. Gut bacterial profiles in Parkinson's disease: A systematic review. CNS Neuroscience & Therapeutics 2023; 29(1): 140 doi: 10.1111/cns.13990
|
| 130 |
Kaixiong Liu, Qifu Guo, Ying Ding, Li Luo, Jianchai Huang, Qijie Zhang. Alterations in nasal microbiota of patients with amyotrophic lateral sclerosis. Chinese Medical Journal 2024; 137(2): 162 doi: 10.1097/CM9.0000000000002701
|
| 131 |
Deniz Erturk‐Hasdemir, Dennis L. Kasper. Finding a needle in a haystack: Bacteroides fragilis polysaccharide A as the archetypical symbiosis factor. Annals of the New York Academy of Sciences 2018; 1417(1): 116 doi: 10.1111/nyas.13660
|
| 132 |
Yun Shi, Chen-Meng Qiao, Yu Zhou, Ji Wu, Chun Cui, Hui Hong, Xue-Bing Jia, Shu-Bing Huang, Li Yao, Wei-Jiang Zhao, Yan-Qin Shen. Protective effects of prucalopride in MPTP-induced Parkinson’s disease mice: Neurochemistry, motor function and gut barrier. Biochemical and Biophysical Research Communications 2021; 556: 16 doi: 10.1016/j.bbrc.2021.03.109
|
| 133 |
Yingjie Shen, Hao Liu, Xiangyi Meng, Aili Gao, Yansong Liu, Wei Ma, Hongsheng Liang, Fulan Hu. The causal effects between gut microbiota and hemorrhagic stroke: a bidirectional two-sample Mendelian randomization study. Frontiers in Microbiology 2023; 14 doi: 10.3389/fmicb.2023.1290909
|
| 134 |
Adonis Sfera, Kelsey Bullock, Amy Price, Luzmin Inderias, Carolina Osorio. Ferrosenescence: The iron age of neurodegeneration?. Mechanisms of Ageing and Development 2018; 174: 63 doi: 10.1016/j.mad.2017.11.012
|
| 135 |
Ai Huey Tan, Jia Wei Hor, Chun Wie Chong, Shen‐Yang Lim. Probiotics for Parkinson's disease: Current evidence and future directions. JGH Open 2021; 5(4): 414 doi: 10.1002/jgh3.12450
|
| 136 |
Lauren Talman, Delaram Safarpour. An Overview of Gastrointestinal Dysfunction in Parkinsonian Syndromes. Seminars in Neurology 2023; 43(04): 583 doi: 10.1055/s-0043-1771461
|
| 137 |
Sophia Alexandre de Queiroz Cavalcanti, Leonardo Augusto de Almeida, Juciano Gasparotto. Effects of a high saturated fatty acid diet on the intestinal microbiota modification and associated impacts on Parkinson's disease development. Journal of Neuroimmunology 2023; 382: 578171 doi: 10.1016/j.jneuroim.2023.578171
|
| 138 |
Shehnaz Wasim, Vishal Kukkar, Vanessa M Awad, Sirisha Sakhamuru, Bilal Haider Malik. Neuroprotective and Neurodegenerative Aspects of Coffee and Its Active Ingredients in View of Scientific Literature. Cureus 2020; doi: 10.7759/cureus.9578
|
| 139 |
Xin Zhao, Juqing Ai, Haoping Mao, Xiumei Gao. Effects of Eclipta prostrata on gut microbiota of SAMP6 mice with osteoporosis. Journal of Medical Microbiology 2019; 68(3): 402 doi: 10.1099/jmm.0.000936
|
| 140 |
Jian-Fu Liao, Yun-Fang Cheng, Shu-Ting You, Wen-Chun Kuo, Chi-Wei Huang, Jen-Jie Chiou, Chih-Chieh Hsu, Hsiu-Mei Hsieh-Li, Sabrina Wang, Ying-Chieh Tsai. Lactobacillus plantarum PS128 alleviates neurodegenerative progression in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse models of Parkinson’s disease. Brain, Behavior, and Immunity 2020; 90: 26 doi: 10.1016/j.bbi.2020.07.036
|
| 141 |
Esmail Alipour Nosrani, Omid Reza Tamtaji, Zahra Alibolandi, Parichehr Sarkar, Mohsen Ghazanfari, Abolfazl Azami Tameh, Mohsen Taghizadeh, Zarrin Banikazemi, Razie Hadavi, Mojtaba Naderi Taheri. Neuroprotective effects of probiotics bacteria on animal model of Parkinson’s disease induced by 6-hydroxydopamine: A behavioral, biochemical, and histological study. Journal of Immunoassay and Immunochemistry 2021; 42(2): 106 doi: 10.1080/15321819.2020.1833917
|
| 142 |
Yogesh Singh, Christoph Trautwein, Joan Romani, Madhuri S. Salker, Peter H. Neckel, Isabel Fraccaroli, Mahkameh Abeditashi, Nils Woerner, Jakob Admard, Achal Dhariwal, Morten K. D. Dueholm, Karl-Herbert Schäfer, Florian Lang, Daniel E. Otzen, Hilal A. Lashuel, Olaf Riess, Nicolas Casadei. Overexpression of human alpha-Synuclein leads to dysregulated microbiome/metabolites with ageing in a rat model of Parkinson disease. Molecular Neurodegeneration 2023; 18(1) doi: 10.1186/s13024-023-00628-1
|
| 143 |
Liqin Liang, Shijia Li, Yuanyuan Huang, Jing Zhou, Dongsheng Xiong, Shaochuan Li, Hehua Li, Baoyuan Zhu, Xiaobo Li, Yuping Ning, Xiaohui Hou, Fengchun Wu, Kai Wu. Relationships among the gut microbiome, brain networks, and symptom severity in schizophrenia patients: A mediation analysis. NeuroImage: Clinical 2024; 41: 103567 doi: 10.1016/j.nicl.2024.103567
|
| 144 |
Lihong Li, Jun Lu, Yingying Sun, Xiaoqing Jin. Acupuncture protects from 6-OHDA-induced neuronal damage by balancing the ratio of DMT1/Fpn1. Saudi Journal of Biological Sciences 2019; 26(8): 1948 doi: 10.1016/j.sjbs.2019.07.003
|
| 145 |
Anshul Sinha, Corinne F. Maurice. Bacteriophages: Uncharacterized and Dynamic Regulators of the Immune System. Mediators of Inflammation 2019; 2019: 1 doi: 10.1155/2019/3730519
|
| 146 |
Disha Tandon, Mohammed Monzoorul Haque, Saravanan R., Shafiq Shaikh, Sriram P., Ashok Kumar Dubey, Sharmila S. Mande, Pankaj Kumar Arora. A snapshot of gut microbiota of an adult urban population from Western region of India. PLOS ONE 2018; 13(4): e0195643 doi: 10.1371/journal.pone.0195643
|
| 147 |
Elizabeth Lipski. Integrative and Functional Medical Nutrition Therapy. 2020; : 367 doi: 10.1007/978-3-030-30730-1_23
|
| 148 |
Artem Minalyan, Lilit Gabrielyan, Claudio Pietra, Yvette Taché, Lixin Wang. Multiple Beneficial Effects of Ghrelin Agonist, HM01 on Homeostasis Alterations in 6-Hydroxydopamine Model of Parkinson’s Disease in Male Rats. Frontiers in Integrative Neuroscience 2019; 13 doi: 10.3389/fnint.2019.00013
|
| 149 |
Geir Bjørklund, Lyudmila Pivina, Maryam Dadar, Nagwa A. Meguid, Yuliya Semenova, Mona Anwar, Salvatore Chirumbolo. Gastrointestinal alterations in autism spectrum disorder: What do we know?. Neuroscience & Biobehavioral Reviews 2020; 118: 111 doi: 10.1016/j.neubiorev.2020.06.033
|
| 150 |
Nicolas A Karakatsanis, Mohammad H Nehmeh, Maurizio Conti, Girish Bal, Antonio J González, Sadek A Nehmeh. Physical performance of adaptive axial FOV PET scanners with a sparse detector block rings or a checkerboard configuration. Physics in Medicine & Biology 2022; 67(10): 105010 doi: 10.1088/1361-6560/ac6aa1
|
| 151 |
Ali Mirza, Yang Mao-Draayer. The gut microbiome and microbial translocation in multiple sclerosis. Clinical Immunology 2017; 183: 213 doi: 10.1016/j.clim.2017.03.001
|
| 152 |
Zijiao Yang, Chengfu Song, Chong Lu. Investigation of the causal relationship between cholelithiasis and Parkinson's disease: A bidirectional Mendelian randomization study. Health Science Reports 2024; 7(10) doi: 10.1002/hsr2.70126
|
| 153 |
Tong Zhang, Rui Yang, Juhua Pan, Shijing Huang. Parkinson’s Disease Related Depression and Anxiety: A 22-Year Bibliometric Analysis (2000-2022). Neuropsychiatric Disease and Treatment 2023; : 1477 doi: 10.2147/NDT.S403002
|
| 154 |
Sarah Vascellari, Vanessa Palmas, Marta Melis, Silvia Pisanu, Roberto Cusano, Paolo Uva, Daniela Perra, Veronica Madau, Marianna Sarchioto, Valentina Oppo, Nicola Simola, Micaela Morelli, Maria Laura Santoru, Luigi Atzori, Maurizio Melis, Giovanni Cossu, Aldo Manzin, Vanni Bucci. Gut Microbiota and Metabolome Alterations Associated with Parkinson’s Disease. mSystems 2020; 5(5) doi: 10.1128/mSystems.00561-20
|
| 155 |
Ai Huey Tan, Chun Wie Chong, Shen‐Yang Lim, Ivan Kok Seng Yap, Cindy Shuan Ju Teh, Mun Fai Loke, Sze‐Looi Song, Jiun Yan Tan, Ban Hong Ang, Yong Qi Tan, Mee Teck Kho, Jeff Bowman, Sanjiv Mahadeva, Hoi Sen Yong, Anthony E. Lang. Gut Microbial Ecosystem in Parkinson Disease: New Clinicobiological Insights from Multi‐Omics. Annals of Neurology 2021; 89(3): 546 doi: 10.1002/ana.25982
|
| 156 |
K Ray Chaudhuri, Nataliya Titova. Societal Burden and Persisting Unmet Needs of Parkinson’s Disease. European Neurological Review 2019; 14(1): 28 doi: 10.17925/ENR.2019.14.1.28
|
| 157 |
Ali Rezaie, Mark Pimentel, Satish S. Rao. How to Test and Treat Small Intestinal Bacterial Overgrowth: an Evidence-Based Approach. Current Gastroenterology Reports 2016; 18(2) doi: 10.1007/s11894-015-0482-9
|
| 158 |
Irene Righetto, Matteo Gasparotto, Laura Casalino, Marcella Vacca, Francesco Filippini. Exogenous Players in Mitochondria-Related CNS Disorders: Viral Pathogens and Unbalanced Microbiota in the Gut-Brain Axis. Biomolecules 2023; 13(1): 169 doi: 10.3390/biom13010169
|
| 159 |
Qinghui He, Congcong Si, Zhenjiao Sun, Yuhui Chen, Xin Zhang. The Intervention of Prebiotics on Depression via the Gut–Brain Axis. Molecules 2022; 27(12): 3671 doi: 10.3390/molecules27123671
|
| 160 |
Sanne van Erp, Ece Ercan, Perla Breedveld, Lianne Brakenhoff, Eidrees Ghariq, Sophie Schmid, Matthias van Osch, Mark van Buchem, Bart Emmer, Jeroen van der Grond, Ron Wolterbeek, Daniel Hommes, Herma Fidder, Nic van der Wee, Tom Huizinga, Désirée van der Heijde, Huub Middelkoop, Itamar Ronen, Andrea van der Meulen-de Jong. Cerebral magnetic resonance imaging in quiescent Crohn’s disease patients with fatigue. World Journal of Gastroenterology 2017; 23(6): 1018-1029 doi: 10.3748/wjg.v23.i6.1018
|
| 161 |
Bai-Hua Sun, Tao Wang, Nian-Ying Li, Qiong Wu, Jin Qiao. Clinical features and relative factors of constipation in a cohort of Chinese patients with Parkinson's disease. World Journal of Gastrointestinal Pharmacology and Therapeutics 2021; 12(1): 21-31 doi: 10.4292/wjgpt.v12.i1.21
|
| 162 |
Mădălina Preda, Mircea Ioan Popa, Mara Mădălina Mihai, Teodora Cristiana Oţelea, Alina Maria Holban. Caffeinated and Cocoa Based Beverages. 2019; : 391 doi: 10.1016/B978-0-12-815864-7.00012-X
|
| 163 |
Mohaddeseh Ghorbani Shiraz, Janni Nielsen, Jeremias Widmann, Ka Hang Karen Chung, Thomas Paul Davis, Casper Rasmussen, Carsten Scavenius, Jan J. Enghild, Camille Martin-Gallausiaux, Yogesh Singh, Ibrahim Javed, Daniel E. Otzen. Young rat microbiota extracts strongly inhibit fibrillation of α-synuclein and protect neuroblastoma cells and zebrafish against α-synuclein toxicity. Molecules and Cells 2025; 48(1): 100161 doi: 10.1016/j.mocell.2024.100161
|
| 164 |
Susan Westfall, Nikita Lomis, Imen Kahouli, Si Yuan Dia, Surya Pratap Singh, Satya Prakash. Microbiome, probiotics and neurodegenerative diseases: deciphering the gut brain axis. Cellular and Molecular Life Sciences 2017; 74(20): 3769 doi: 10.1007/s00018-017-2550-9
|
| 165 |
Gagandeep Kaur, Tapan Behl, Simona Bungau, Arun Kumar, Md. Sahab Uddin, Vineet Mehta, Gokhan Zengin, Bijo Mathew, Muhammad Ajmal Shah, Sandeep Arora. Dysregulation of the Gut-Brain Axis, Dysbiosis and Influence of Numerous Factors on Gut Microbiota Associated Parkinson’s Disease. Current Neuropharmacology 2020; 19(2): 233 doi: 10.2174/1570159X18666200606233050
|
| 166 |
Qiang Fu, Siyi Zhou, Mengting Yu, Yang Lu, Genhe He, Xiaoliu Huang, Yushan Huang. Portulaca oleracea Polysaccharides Modulate Intestinal Microflora in Aged Rats in vitro. Frontiers in Microbiology 2022; 13 doi: 10.3389/fmicb.2022.841397
|
| 167 |
|
| 168 |
Maria Belen Justich, Olga L. Rojas, Alfonso Fasano. The Role of Helicobacter pylori and Small Intestinal Bacterial Overgrowth in Parkinson's Disease. Seminars in Neurology 2023; 43(04): 553 doi: 10.1055/s-0043-1771468
|
| 169 |
Paolo Riccio, Rocco Rossano. Undigested Food and Gut Microbiota May Cooperate in the Pathogenesis of Neuroinflammatory Diseases: A Matter of Barriers and a Proposal on the Origin of Organ Specificity. Nutrients 2019; 11(11): 2714 doi: 10.3390/nu11112714
|
| 170 |
Stroe Alina Zorina. Cancer in Parkinson’s Disease, a Review of Literature. ARS Medica Tomitana 2021; 27(4): 175 doi: 10.2478/arsm-2021-0034
|
| 171 |
Xiuli Lin, Yingying Liu, Lili Ma, Xiaomeng Ma, Liping Shen, Xueying Ma, Zhaoyu Chen, Hao Chen, Donghong Li, Zhumin Su, Xiaohong Chen. Constipation induced gut microbiota dysbiosis exacerbates experimental autoimmune encephalomyelitis in C57BL/6 mice. Journal of Translational Medicine 2021; 19(1) doi: 10.1186/s12967-021-02995-z
|
| 172 |
Gözde EMİNOĞLU. Beslenmenin Psikolojik Durum Üzerinde Olumlu ya da Olumsuz Etkisinin Araştırılması: Üniversite Öğrencilerinde Bir Anket Çalışması. Düzce Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi 2020; doi: 10.33631/duzcesbed.762252
|
| 173 |
Leszek Szablewski. Comprehensive Gut Microbiota. 2022; : 423 doi: 10.1016/B978-0-12-819265-8.00065-6
|
| 174 |
Kirsi Murtomäki, Juho Joutsa, Tuomas Mertsalmi, Elina Jaakkola, Elina Mäkinen, Reeta Levo, Mikael Eklund, Simo Nuuttila, Eero Pekkonen, Tommi Noponen, Toni Ihalainen, Valtteri Kaasinen, Filip Scheperjans. Dopamine transporter binding in the brain is linked to irritable bowel syndrome in Parkinson's disease. Brain and Behavior 2023; 13(7) doi: 10.1002/brb3.3097
|
| 175 |
Joy Leng, Chris Proudman, Alistair Darby, Frances Blow, Neil Townsend, Andrew Miller, Jonathan Swann. Exploration of the Fecal Microbiota and Biomarker Discovery in Equine Grass Sickness. Journal of Proteome Research 2018; 17(3): 1120 doi: 10.1021/acs.jproteome.7b00784
|
| 176 |
Thomas Foki, Birgit Riemer, Bianca Brim, Walter Struhal. Non-Motor Parkinson's Disease. 2022; : 130 doi: 10.1017/9781009039291.013
|
| 177 |
Laura de Magistris, Dario Siniscalco, Carmela Bravaccio, Carmelina Loguercio. Human Nutrition from the Gastroenterologist’s Perspective. 2016; : 49 doi: 10.1007/978-3-319-30361-1_4
|
| 178 |
Yumna El-Hakim, Kathiresh Kumar Mani, Kaylin A. Pickle, Zara Akbari, Nadia Samiya, Chloe Pham, Gianna Salas, Rachel Pilla, Farida Sohrabji. Peripheral, but not central, IGF-1 treatment attenuates stroke-induced cognitive impairment in middle-aged female Sprague Dawley rats: The gut as a therapeutic target. Brain, Behavior, and Immunity 2024; 122: 150 doi: 10.1016/j.bbi.2024.08.008
|
| 179 |
Lady Johanna Forero-Rodríguez, Jonathan Josephs-Spaulding, Stefano Flor, Andrés Pinzón, Christoph Kaleta. Parkinson’s Disease and the Metal–Microbiome–Gut–Brain Axis: A Systems Toxicology Approach. Antioxidants 2021; 11(1): 71 doi: 10.3390/antiox11010071
|
| 180 |
Karol Kowalski, Agata Mulak. Brain-Gut-Microbiota Axis in Alzheimer’s Disease. Journal of Neurogastroenterology and Motility 2019; 25(1): 48 doi: 10.5056/jnm18087
|
| 181 |
Melania Melis, Antje Haehner, Mariano Mastinu, Thomas Hummel, Iole Tomassini Barbarossa. Molecular and Genetic Factors Involved in Olfactory and Gustatory Deficits and Associations with Microbiota in Parkinson’s Disease. International Journal of Molecular Sciences 2021; 22(8): 4286 doi: 10.3390/ijms22084286
|
| 182 |
Petros Georgopoulos, Konstantinos-Vaios Mytilekas, Apostolos Apostolidis. Neuro-Urology. 2018; : 55 doi: 10.1007/978-3-319-90997-4_5
|
| 183 |
Xin Liu, Zhong-Rui Du, Xiong Wang, Kar-Him Luk, Cheuk-Hin Chan, Xu Cao, Qing Zhao, Fang Zhao, Wing-Tak Wong, Ka-Hing Wong, Xiao-Li Dong. Colonic Dopaminergic Neurons Changed Reversely With Those in the Midbrain via Gut Microbiota-Mediated Autophagy in a Chronic Parkinson’s Disease Mice Model. Frontiers in Aging Neuroscience 2021; 13 doi: 10.3389/fnagi.2021.649627
|
| 184 |
Xiao-Chong Li, Bang-Sheng Wu, Yi Jiang, Jie Li, Ze-Fen Wang, Chao Ma, Yi-Rong Li, Jie Yao, Xiao-Qing Jin, Zhi-Qiang Li. Temozolomide-Induced Changes in Gut Microbial Composition in a Mouse Model of Brain Glioma. Drug Design, Development and Therapy 2021; : 1641 doi: 10.2147/DDDT.S298261
|
| 185 |
Xinfu Zou, Guoqiang Zou, Xinyan Zou, Kangfeng Wang, Zetao Chen. Gut microbiota and its metabolites in Alzheimer’s disease: from pathogenesis to treatment. PeerJ 2024; 12: e17061 doi: 10.7717/peerj.17061
|
| 186 |
Teodora Surdea Blaga, Dan L. Dumitrascu, Andrei V. Pop, Simona Grad. The Complex Interplay Between Gut-Brain, Gut-Liver, and Liver-Brain Axes. 2021; : 17 doi: 10.1016/B978-0-12-821927-0.00008-5
|
| 187 |
George B. Stefano, Richard M. Kream. Mitochondrial DNA Heteroplasmy as an Informational Reservoir Dynamically Linked to Metabolic and Immunological Processes Associated with COVID-19 Neurological Disorders. Cellular and Molecular Neurobiology 2022; 42(1): 99 doi: 10.1007/s10571-021-01117-z
|
| 188 |
Diego Cabezudo, Veerle Baekelandt, Evy Lobbestael. Multiple-Hit Hypothesis in Parkinson’s Disease: LRRK2 and Inflammation. Frontiers in Neuroscience 2020; 14 doi: 10.3389/fnins.2020.00376
|
| 189 |
Roberta J. Ward, David T. Dexter, Robert R. Crichton. Iron, Neuroinflammation and Neurodegeneration. International Journal of Molecular Sciences 2022; 23(13): 7267 doi: 10.3390/ijms23137267
|
| 190 |
Oksana Zatorska. Impact of gut microbiota on the central nervous system relevance in neurodegenerative and psychiatric diseases. Current Problems of Psychiatry 2024; 25: 239 doi: 10.12923/2353-8627/2024-0022
|
| 191 |
Yasir Bashir, Asad U. Khan. The interplay between the gut-brain axis and the microbiome: A perspective on psychiatric and neurodegenerative disorders. Frontiers in Neuroscience 2022; 16 doi: 10.3389/fnins.2022.1030694
|
| 192 |
Zhengjia Pu, Shuya Liu, Zeming Guo, Xuemei Zhang, Jie Yan, Yong Tang, Hong Xiao, Jieying Gao, Yingli Li, Qunhua Bai. Casein Reactivates Dopaminergic Nerve Injury and Intestinal Inflammation with Disturbing Intestinal Microflora and Fecal Metabolites in a Convalescent Parkinson's Disease Mouse Model. Neuroscience 2023; 524: 120 doi: 10.1016/j.neuroscience.2023.05.014
|
| 193 |
Sara Ekmark‐Lewén, Veronica Lindström, Astrid Gumucio, Elisabeth Ihse, Anish Behere, Philipp J. Kahle, Eva Nordström, Maria Eriksson, Anna Erlandsson, Joakim Bergström, Martin Ingelsson. Early fine motor impairment and behavioral dysfunction in (Thy‐1)‐h[A30P] alpha‐synuclein mice. Brain and Behavior 2018; 8(3) doi: 10.1002/brb3.915
|
| 194 |
Navid Leelani, Petar Bajic, Neel Parekh, Sarah C. Vij, Scott D. Lundy. The emerging role of the gut-testis axis in male reproductive health and infertility. F&S Reviews 2023; 4(2): 131 doi: 10.1016/j.xfnr.2023.01.001
|
| 195 |
Li Liu, Yan Zhao, Weixing Yang, Yuqin Fan, Lixiang Han, Jun Sheng, Yang Tian, Xiaoyu Gao. Rotenone Induces Parkinsonism with Constipation Symptoms in Mice by Disrupting the Gut Microecosystem, Inhibiting the PI3K-AKT Signaling Pathway and Gastrointestinal Motility. International Journal of Molecular Sciences 2025; 26(5): 2079 doi: 10.3390/ijms26052079
|
| 196 |
Saba Kurtom, Vrishketan Sethi, Vikas Dudeja. Textbook of Pancreatic Cancer. 2021; : 267 doi: 10.1007/978-3-030-53786-9_19
|
| 197 |
Subramanian Thangaleela, Bhagavathi Sundaram Sivamaruthi, Periyanaina Kesika, Muruganantham Bharathi, Chaiyavat Chaiyasut. Role of the Gut–Brain Axis, Gut Microbial Composition, Diet, and Probiotic Intervention in Parkinson’s Disease. Microorganisms 2022; 10(8): 1544 doi: 10.3390/microorganisms10081544
|
| 198 |
Jingyi He, Guofu Zhu, Guoqing Wang, Feng Zhang. Oxidative Stress and Neuroinflammation Potentiate Each Other to Promote Progression of Dopamine Neurodegeneration. Oxidative Medicine and Cellular Longevity 2020; 2020: 1 doi: 10.1155/2020/6137521
|
| 199 |
Jacopo Troisi, Annamaria Landolfi, Pierpaolo Cavallo, Francesca Marciano, Paolo Barone, Marianna Amboni. . Advances in Clinical Chemistry 2021; 104: 107 doi: 10.1016/bs.acc.2020.09.003
|
| 200 |
Mouhammad Sharifa, Tanmay Ghosh, Omar A Daher , Pramod Bhusal, Yasoob A Alaameri, Javeria Naz, Chukwuyem Ekhator , Sophia B Bellegarde, Pakeezah Bisharat, Viralkumar Vaghani, Azlaan Hussain. Unraveling the Gut-Brain Axis in Multiple Sclerosis: Exploring Dysbiosis, Oxidative Stress, and Therapeutic Insights. Cureus 2023; doi: 10.7759/cureus.47058
|
| 201 |
Nicola Principi, Susanna Esposito. Gut microbiota and central nervous system development. Journal of Infection 2016; 73(6): 536 doi: 10.1016/j.jinf.2016.09.010
|
| 202 |
Agnieszka Gadecka, Anna Bielak-Zmijewska. Slowing Down Ageing: The Role of Nutrients and Microbiota in Modulation of the Epigenome. Nutrients 2019; 11(6): 1251 doi: 10.3390/nu11061251
|
| 203 |
Ai Huey Tan, Shen Yang Lim, Anthony E. Lang. The microbiome–gut–brain axis in Parkinson disease — from basic research to the clinic. Nature Reviews Neurology 2022; 18(8): 476 doi: 10.1038/s41582-022-00681-2
|
| 204 |
Qin Zhang, Kangyu Jin, Bing Chen, Ripeng Liu, Shangping Cheng, Yuyan Zhang, Jing Lu. Overnutrition Induced Cognitive Impairment: Insulin Resistance, Gut-Brain Axis, and Neuroinflammation. Frontiers in Neuroscience 2022; 16 doi: 10.3389/fnins.2022.884579
|
| 205 |
Jing-Jing Shi, Cheng-Yuan Mao, Ya-Zhou Guo, Yu Fan, Xiao-Yan Hao, Shuang-Jie Li, Jie Tian, Zheng-Wei Hu, Meng-Jie Li, Jia-Di Li, Dong-Rui Ma, Meng-Nan Guo, Chun-Yan Zuo, Yuan-Yuan Liang, Yu-Ming Xu, Jian Yang, Chang-He Shi. Joint analysis of proteome, transcriptome, and multi-trait analysis to identify novel Parkinson’s disease risk genes. Aging 2024; 16(2): 1555 doi: 10.18632/aging.205444
|
| 206 |
Scott A. Myers, Leila Gobejishvili, Sujata Saraswat Ohri, C. Garrett Wilson, Kariena R. Andres, Amberly S. Riegler, Hridgandh Donde, Swati Joshi-Barve, Shirish Barve, Scott R. Whittemore. Following spinal cord injury, PDE4B drives an acute, local inflammatory response and a chronic, systemic response exacerbated by gut dysbiosis and endotoxemia. Neurobiology of Disease 2019; 124: 353 doi: 10.1016/j.nbd.2018.12.008
|
| 207 |
Martha Teresa Acosta-Mejia, Nelson Villalobos. Neurophysiology of Brain Networks Underlies Symptoms of Parkinson’s Disease: A Basis for Diagnosis and Management. Diagnostics 2023; 13(14): 2394 doi: 10.3390/diagnostics13142394
|
| 208 |
Robert P. Smith, Cole Easson, Sarah M. Lyle, Ritishka Kapoor, Chase P. Donnelly, Eileen J. Davidson, Esha Parikh, Jose V. Lopez, Jaime L. Tartar, Palok Aich. Gut microbiome diversity is associated with sleep physiology in humans. PLOS ONE 2019; 14(10): e0222394 doi: 10.1371/journal.pone.0222394
|
| 209 |
Caroline Haikal, Qian-Qian Chen, Jia-Yi Li. Microbiome changes: an indicator of Parkinson’s disease?. Translational Neurodegeneration 2019; 8(1) doi: 10.1186/s40035-019-0175-7
|
| 210 |
Kaberi Chatterjee, Sugato Banerjee. The Microbiome. Progress in Molecular Biology and Translational Science 2020; 176: 111 doi: 10.1016/bs.pmbts.2020.08.010
|
| 211 |
Xueling Zhu, Bo Li, Pengcheng Lou, Tingting Dai, Yang Chen, Aoxiang Zhuge, Yin Yuan, Lanjuan Li. The Relationship Between the Gut Microbiome and Neurodegenerative Diseases. Neuroscience Bulletin 2021; 37(10): 1510 doi: 10.1007/s12264-021-00730-8
|
| 212 |
Grace Hey, Navya Nair, Emily Klann, Anjela Gurrala, Delaram Safarpour, Volker Mai, Adolfo Ramirez-Zamora, Vinata Vedam-Mai. Therapies for Parkinson’s disease and the gut microbiome: evidence for bidirectional connection. Frontiers in Aging Neuroscience 2023; 15 doi: 10.3389/fnagi.2023.1151850
|
| 213 |
Xiaoqing Li, Xin Feng, Zhongxiang Jiang, Zheng Jiang. Association of small intestinal bacterial overgrowth with Parkinson’s disease: a systematic review and meta-analysis. Gut Pathogens 2021; 13(1) doi: 10.1186/s13099-021-00420-w
|
| 214 |
Chen Song, Fangyuan Duan, Ting Ju, Yue Qin, Deyong Zeng, Shan Shan, Yudong Shi, Yingchun Zhang, Weihong Lu. Eleutheroside E supplementation prevents radiation-induced cognitive impairment and activates PKA signaling via gut microbiota. Communications Biology 2022; 5(1) doi: 10.1038/s42003-022-03602-7
|
| 215 |
Joyce K. Y. Tse. Gut Microbiota, Nitric Oxide, and Microglia as Prerequisites for Neurodegenerative Disorders. ACS Chemical Neuroscience 2017; 8(7): 1438 doi: 10.1021/acschemneuro.7b00176
|
| 216 |
Prisca Gebrayel, Carole Nicco, Souhaila Al Khodor, Jaroslaw Bilinski, Elisabetta Caselli, Elena M. Comelli, Markus Egert, Cristina Giaroni, Tomasz M. Karpinski, Igor Loniewski, Agata Mulak, Julie Reygner, Paulina Samczuk, Matteo Serino, Mariusz Sikora, Annalisa Terranegra, Marcin Ufnal, Romain Villeger, Chantal Pichon, Peter Konturek, Marvin Edeas. Microbiota medicine: towards clinical revolution. Journal of Translational Medicine 2022; 20(1) doi: 10.1186/s12967-022-03296-9
|
| 217 |
E. Fernández-Espejo. Microorganismos relacionados con un mayor riesgo de presentar la enfermedad de Parkinson. Neurología 2023; 38(7): 495 doi: 10.1016/j.nrl.2020.08.020
|
| 218 |
Hao Cheng, Dandan Zhang, Jing Wu, Juan Liu, Yaochuan Zhou, Yuzhu Tan, Wuwen Feng, Cheng Peng. Interactions between gut microbiota and polyphenols: A mechanistic and metabolomic review. Phytomedicine 2023; 119: 154979 doi: 10.1016/j.phymed.2023.154979
|
| 219 |
Bilal El-Mansoury, Kamal Smimih, Abdelaati El Khiat, Hanane El Fatimi, Abdelmohcine Aimrane, Soraia El Baz, Abdessamad Elmourid, Fatima Ez-Zahraa Saad, Hafida El Ghachi, Manal Khanouchi, Arumugam Radhakrishnan Jayakumar, Abdeljalil Zoubadi. Experimental and Clinical Evidence of the Neuropathology of Parkinson’s Disease. Advances in Medical Diagnosis, Treatment, and Care 2023; : 296 doi: 10.4018/978-1-6684-5156-4.ch017
|
| 220 |
María Paz Valdivieso Castro, Julio Cesar Ojeda Sánchez, Jorge Eduardo Ochoa Aucay. The role of the intestine as a target with a therapeutic role in people with neurodegenerative diseases. Salud, Ciencia y Tecnología 2023; 3: 310 doi: 10.56294/saludcyt2023310
|
| 221 |
Loredana Matiș, Lucia Georgeta Daina, Lavinia Maris, Timea Claudia Ghitea, Daniela Florina Trifan, Ioana Moga, Radu Fodor. Variety of Serotonin Levels in Pediatric Gastrointestinal Disorders. Diagnostics 2023; 13(24): 3675 doi: 10.3390/diagnostics13243675
|
| 222 |
Alba Montalbán-Rodríguez, Raquel Abalo, Laura López-Gómez. From the Gut to the Brain: The Role of Enteric Glial Cells and Their Involvement in the Pathogenesis of Parkinson’s Disease. International Journal of Molecular Sciences 2024; 25(2): 1294 doi: 10.3390/ijms25021294
|
| 223 |
Shaosong Xi, Yunguang Wang, Chenghao Wu, Weihua Peng, Ying Zhu, Wei Hu. Intestinal Epithelial Cell Exosome Launches IL-1β-Mediated Neuron Injury in Sepsis-Associated Encephalopathy. Frontiers in Cellular and Infection Microbiology 2022; 11 doi: 10.3389/fcimb.2021.783049
|
| 224 |
Corneliu Toader, Calin Petru Tataru, Octavian Munteanu, Razvan-Adrian Covache-Busuioc, Matei Serban, Alexandru Vlad Ciurea, Mihaly Enyedi. Revolutionizing Neuroimmunology: Unraveling Immune Dynamics and Therapeutic Innovations in CNS Disorders. International Journal of Molecular Sciences 2024; 25(24): 13614 doi: 10.3390/ijms252413614
|
| 225 |
Xuxiang Zhang, Beisha Tang, Jifeng Guo. Parkinson’s disease and gut microbiota: from clinical to mechanistic and therapeutic studies. Translational Neurodegeneration 2023; 12(1) doi: 10.1186/s40035-023-00392-8
|
| 226 |
Anna Onisiforou, George M Spyrou. Identification of viral-mediated pathogenic mechanisms in neurodegenerative diseases using network-based approaches. Briefings in Bioinformatics 2021; 22(6) doi: 10.1093/bib/bbab141
|
| 227 |
Bo Ram Beck, Gun-Seok Park, Do Yeun Jeong, Yong Hyun Lee, Sunghoon Im, Won Ho Song, Jihee Kang. Multidisciplinary and Comparative Investigations of Potential Psychobiotic Effects of Lactobacillus Strains Isolated From Newborns and Their Impact on Gut Microbiota and Ileal Transcriptome in a Healthy Murine Model. Frontiers in Cellular and Infection Microbiology 2019; 9 doi: 10.3389/fcimb.2019.00269
|
| 228 |
Shima Mehrabadi, Seyed Shahabeddin Sadr. Assessment of Probiotics Mixture on Memory Function, Inflammation Markers, and Oxidative Stress in an Alzheimer's Disease Model of Rats. Iranian Biomedical Journal 2020; 24(4): 220 doi: 10.29252/ibj.24.4.220
|
| 229 |
Vibeke D. Valderhaug, Kristine Heiney, Ola Huse Ramstad, Geir Bråthen, Wei-Li Kuan, Stefano Nichele, Axel Sandvig, Ioanna Sandvig. Early functional changes associated with alpha-synuclein proteinopathy in engineered human neural networks. American Journal of Physiology-Cell Physiology 2021; 320(6): C1141 doi: 10.1152/ajpcell.00413.2020
|
| 230 |
Huajun Pan, Zhigang Liu. Molecular Nutrition and Mitochondria. 2023; : 243 doi: 10.1016/B978-0-323-90256-4.00024-2
|
| 231 |
Subhashree Priyadarsini, Moumita Sahoo, Swetapadma Sahu, Rasu Jayabalan, Monalisa Mishra. An infection of Enterobacter ludwigii affects development and causes age-dependent neurodegeneration in Drosophila melanogaster. Invertebrate Neuroscience 2019; 19(4) doi: 10.1007/s10158-019-0233-y
|
| 232 |
Qingchun Lei, Tingting Wu, Jin Wu, Xiaogang Hu, Yingxia Guan, Ying Wang, Jinyuan Yan, Guolin Shi. Roles of α‑synuclein in gastrointestinal microbiome dysbiosis‑related Parkinson's disease progression (Review). Molecular Medicine Reports 2021; 24(4) doi: 10.3892/mmr.2021.12374
|
| 233 |
Kejia Xu, Qiong Huang, Ying Lyu, Shuyan Wang, Yinzhong Lu, Gang Qian. Phosphatidylserine improves aging sepsis survival, modulates gut microbiome, and prevents sepsis-associated encephalopathy. Biomedicine & Pharmacotherapy 2024; 178: 117200 doi: 10.1016/j.biopha.2024.117200
|
| 234 |
Aaron Lerner, Torsten Matthias. Don’t forget the exogenous microbial transglutaminases: it is immunogenic and potentially pathogenic. AIMS Biophysics 2016; 3(4): 546 doi: 10.3934/biophy.2016.4.546
|
| 235 |
Briana R. De Miranda, J. Timothy Greenamyre. Trichloroethylene, a ubiquitous environmental contaminant in the risk for Parkinson's disease. Environmental Science: Processes & Impacts 2020; 22(3): 543 doi: 10.1039/C9EM00578A
|
| 236 |
Saravana Babu Chidambaram, Musthafa Mohamed Essa, A.G. Rathipriya, Muhammed Bishir, Bipul Ray, Arehally M. Mahalakshmi, A.H. Tousif, Meena K. Sakharkar, Rajpal Singh Kashyap, Robert P. Friedland, Tanya M. Monaghan. Gut dysbiosis, defective autophagy and altered immune responses in neurodegenerative diseases: Tales of a vicious cycle. Pharmacology & Therapeutics 2022; 231: 107988 doi: 10.1016/j.pharmthera.2021.107988
|
| 237 |
Stephan Klatt, James D. Doecke, Anne Roberts, Berin A. Boughton, Colin L. Masters, Malcolm Horne, Blaine R. Roberts. A six-metabolite panel as potential blood-based biomarkers for Parkinson’s disease. npj Parkinson's Disease 2021; 7(1) doi: 10.1038/s41531-021-00239-x
|
| 238 |
Siyu Dong, Mei Sun, Chuan He, Hong Cheng. Brain-gut-microbiota axis in Parkinson’s disease: A historical review and future perspective. Brain Research Bulletin 2022; 183: 84 doi: 10.1016/j.brainresbull.2022.02.015
|
| 239 |
Arman Rahmim, Martin A. Lodge, Nicolas A. Karakatsanis, Vladimir Y. Panin, Yun Zhou, Alan McMillan, Steve Cho, Habib Zaidi, Michael E. Casey, Richard L. Wahl. Dynamic whole-body PET imaging: principles, potentials and applications. European Journal of Nuclear Medicine and Molecular Imaging 2019; 46(2): 501 doi: 10.1007/s00259-018-4153-6
|
| 240 |
|
| 241 |
Rebekah Rajiah, Kazuya Takahashi, Qasim Aziz, James K. Ruffle. Brain effect of transcutaneous vagal nerve stimulation: A meta‐analysis of neuroimaging evidence. Neurogastroenterology & Motility 2024; 36(8) doi: 10.1111/nmo.14484
|
| 242 |
Tariq Ismail, Sabrina Donati-Zeppa, Saeed Akhtar, Eleonora Turrini, Anam Layla, Piero Sestili, Carmela Fimognari. Coffee in cancer chemoprevention: an updated review. Expert Opinion on Drug Metabolism & Toxicology 2021; 17(1): 69 doi: 10.1080/17425255.2021.1839412
|
| 243 |
Ying Yang, Shili Liu, Yihua Wang, Zhibin Wang, Wenyu Ding, Xiaoyuan Sun, Kunlun He, Qiang Feng, Xiandang Zhang. Changes of saliva microbiota in the onset and after the treatment of diabetes in patients with periodontitis. Aging 2020; 12(13): 13090 doi: 10.18632/aging.103399
|
| 244 |
Inês C. Brás, Tiago F. Outeiro. Alpha-Synuclein: Mechanisms of Release and Pathology Progression in Synucleinopathies. Cells 2021; 10(2): 375 doi: 10.3390/cells10020375
|
| 245 |
Ying Chen, Dongwei Wang, Yinsheng Liao, Gang Zuo, Xiaojun Lu. The complex relationship between the microbiota-gut-brain axis and neurodegenerative diseases and future perspectives. Discover Medicine 2024; 1(1) doi: 10.1007/s44337-024-00135-2
|
| 246 |
Elisabetta Damiani, Rosita Gabbianelli. Early Life Origins of Ageing and Longevity. Healthy Ageing and Longevity 2019; 9: 167 doi: 10.1007/978-3-030-24958-8_9
|
| 247 |
Bang-rong Wei, Yu-jia Zhao, Yu-feng Cheng, Chun Huang, Feng Zhang. Helicobacter pylori infection and Parkinson’s Disease: etiology, pathogenesis and levodopa bioavailability. Immunity & Ageing 2024; 21(1) doi: 10.1186/s12979-023-00404-1
|
| 248 |
Wei Tao, Yanren Zhang, Bingbin Wang, Saiqun Nie, Li Fang, Jian Xiao, Yanqing Wu. Advances in molecular mechanisms and therapeutic strategies for central nervous system diseases based on gut microbiota imbalance. Journal of Advanced Research 2025; 69: 261 doi: 10.1016/j.jare.2024.03.023
|
| 249 |
Pengfei Fu, Meng Gao, Ken Kin Lam Yung. Association of Intestinal Disorders with Parkinson’s Disease and Alzheimer’s Disease: A Systematic Review and Meta-Analysis. ACS Chemical Neuroscience 2020; 11(3): 395 doi: 10.1021/acschemneuro.9b00607
|
| 250 |
Amaia Iriondo-DeHond, José Antonio Uranga, Maria Dolores del Castillo, Raquel Abalo. Effects of Coffee and Its Components on the Gastrointestinal Tract and the Brain–Gut Axis. Nutrients 2020; 13(1): 88 doi: 10.3390/nu13010088
|
| 251 |
Mohamed A. Farag, Martin von Bergen, Basma M. Saleh, Masun Nabhan Homsi, Mohamed S. Abd El-Al. How do green and black coffee brews and bioactive interaction with gut microbiome affect its health outcomes? Mining evidence from mechanistic studies, metagenomics and clinical trials. Trends in Food Science & Technology 2021; 118: 920 doi: 10.1016/j.tifs.2021.11.004
|
| 252 |
Jessica Y. Vargas, Clara Grudina, Chiara Zurzolo. The prion-like spreading of α-synuclein: From in vitro to in vivo models of Parkinson’s disease. Ageing Research Reviews 2019; 50: 89 doi: 10.1016/j.arr.2019.01.012
|
| 253 |
Yumna El-Hakim, Kathiresh Kumar Mani, Amir Eldouh, Sivani Pandey, Maria T. Grimaldo, Alan Dabney, Rachel Pilla, Farida Sohrabji. Sex differences in stroke outcome correspond to rapid and severe changes in gut permeability in adult Sprague-Dawley rats. Biology of Sex Differences 2021; 12(1) doi: 10.1186/s13293-020-00352-1
|
| 254 |
奕玮 聂. To Explore the Mechanism of Alzheimer’s Disease Based on Brain-Gut Axis Theory. Hans Journal of Biomedicine 2023; 13(02): 121 doi: 10.12677/HJBM.2023.132013
|
| 255 |
Carley Rusch, Matthew Beke, Carmelo Nieves, Volker Mai, Tamara Stiep, Tracy Tholanikunnel, Adolfo Ramirez-Zamora, Christopher W. Hess, Bobbi Langkamp-Henken. Promotion of a Mediterranean Diet Alters Constipation Symptoms and Fecal Calprotectin in People with Parkinson’s Disease: A Randomized Controlled Trial. Nutrients 2024; 16(17): 2946 doi: 10.3390/nu16172946
|
| 256 |
Bei Gao, Liang Chi, Pengcheng Tu, Nan Gao, Kun Lu. The Carbamate Aldicarb Altered the Gut Microbiome, Metabolome, and Lipidome of C57BL/6J Mice. Chemical Research in Toxicology 2019; 32(1): 67 doi: 10.1021/acs.chemrestox.8b00179
|
| 257 |
Peng-Ning Wu, Shuai Xiong, Peng Zhong, Wan-Qing Yang, Min Chen, Tai-Chun Tang. Global trends in research on irritable bowel syndrome and the brain–gut axis: Bibliometrics and visualization analysis. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.956204
|
| 258 |
Nicola Principi, Rita Cozzali, Edoardo Farinelli, Andrea Brusaferro, Susanna Esposito. Gut dysbiosis and irritable bowel syndrome: The potential role of probiotics. Journal of Infection 2018; 76(2): 111 doi: 10.1016/j.jinf.2017.12.013
|
| 259 |
Jigar Bhagatwala, Satish S.C. Rao. Clinical and Basic Neurogastroenterology and Motility. 2020; : 343 doi: 10.1016/B978-0-12-813037-7.00024-8
|
| 260 |
Clara Bullich, Ali Keshavarzian, Johan Garssen, Aletta Kraneveld, Paula Perez‐Pardo. Gut Vibes in Parkinson's Disease: The Microbiota‐Gut‐Brain Axis. Movement Disorders Clinical Practice 2019; 6(8): 639 doi: 10.1002/mdc3.12840
|
| 261 |
An-Di Chen, Jia-Xin Cao, Hai-Chao Chen, Hong-Li Du, Xiao-Xia Xi, Jing Sun, Jie Yin, Yu-Hong Jing, Li-Ping Gao. Rotenone aggravates PD-like pathology in A53T mutant human α-synuclein transgenic mice in an age-dependent manner. Frontiers in Aging Neuroscience 2022; 14 doi: 10.3389/fnagi.2022.842380
|
| 262 |
Valentina Caputi, Maria Cecilia Giron. Microbiome-Gut-Brain Axis and Toll-Like Receptors in Parkinson’s Disease. International Journal of Molecular Sciences 2018; 19(6): 1689 doi: 10.3390/ijms19061689
|
| 263 |
Leszek Szablewski. Human Gut Microbiota in Health and Alzheimer’s Disease. Journal of Alzheimer’s Disease 2018; 62(2): 549 doi: 10.3233/JAD-170908
|
| 264 |
Yusuke Kawashima, Eiichiro Watanabe, Taichi Umeyama, Daisuke Nakajima, Masahira Hattori, Kenya Honda, Osamu Ohara. Optimization of Data-Independent Acquisition Mass Spectrometry for Deep and Highly Sensitive Proteomic Analysis. International Journal of Molecular Sciences 2019; 20(23): 5932 doi: 10.3390/ijms20235932
|
| 265 |
Rebecca L. Wallings, Mary K. Herrick, Malú Gámez Tansey. LRRK2 at the Interface Between Peripheral and Central Immune Function in Parkinson’s. Frontiers in Neuroscience 2020; 14 doi: 10.3389/fnins.2020.00443
|
| 266 |
Sanaz Salaramoli, Hamid Reza Joshaghani, Seyed Isaac Hashemy, Mamede de Carvalho. Salivary Biomarkers: Noninvasive Ways for Diagnosis of Parkinson’s Disease. Neurology Research International 2023; 2023: 1 doi: 10.1155/2023/3555418
|
| 267 |
Devaraja Gayathri, Mahanthesh Vasudha, Chakra Siddappa Prashantkumar. Microbiome-Gut-Brain Axis. 2022; : 261 doi: 10.1007/978-981-16-1626-6_11
|
| 268 |
Shui Yu, Hai-rong Peng, Yu-kai Zhang, Yan-qing Yin, Jia-wei Zhou. Central dopaminergic control of cell proliferation in the colonic epithelium. Neuroscience Research 2022; 180: 72 doi: 10.1016/j.neures.2022.02.006
|
| 269 |
Eamonn M. M. Quigley. Microbiota-Brain-Gut Axis and Neurodegenerative Diseases. Current Neurology and Neuroscience Reports 2017; 17(12) doi: 10.1007/s11910-017-0802-6
|
| 270 |
Yogesh Singh, Mohamed El-Hadidi, Jakob Admard, Zinah Wassouf, Julia M. Schulze-Hentrich, Ursula Kohlhofer, Leticia Quintanilla-Martinez, Daniel Huson, Olaf Riess, Nicolas Casadei. Enriched Environmental Conditions Modify the Gut Microbiome Composition and Fecal Markers of Inflammation in Parkinson’s Disease. Frontiers in Neuroscience 2019; 13 doi: 10.3389/fnins.2019.01032
|
| 271 |
Mark Pimentel, Richard J. Saad, Millie D. Long, Satish S. C. Rao. ACG Clinical Guideline: Small Intestinal Bacterial Overgrowth. American Journal of Gastroenterology 2020; 115(2): 165 doi: 10.14309/ajg.0000000000000501
|
| 272 |
Samuel Strader, Andrew B. West. The interplay between monocytes, α-synuclein and LRRK2 in Parkinson's disease. Biochemical Society Transactions 2023; 51(2): 747 doi: 10.1042/BST20201091
|
| 273 |
Yoona Kim, Peter Clifton. Curcumin, Cardiometabolic Health and Dementia. International Journal of Environmental Research and Public Health 2018; 15(10): 2093 doi: 10.3390/ijerph15102093
|
| 274 |
Paula Perez-Pardo, Mitch Hartog, Johan Garssen, Aletta D. Kraneveld. Microbes Tickling Your Tummy: the Importance of the Gut-Brain Axis in Parkinson’s Disease. Current Behavioral Neuroscience Reports 2017; 4(4): 361 doi: 10.1007/s40473-017-0129-2
|
| 275 |
Jie-jun Zhou, Lei Chun, Jian-feng Liu. A Comprehensive Understanding of Dietary Effects on C. elegans Physiology. Current Medical Science 2019; 39(5): 679 doi: 10.1007/s11596-019-2091-6
|
| 276 |
Michal Lubomski, Ai Huey Tan, Shen-Yang Lim, Andrew J. Holmes, Ryan L. Davis, Carolyn M. Sue. Parkinson’s disease and the gastrointestinal microbiome. Journal of Neurology 2020; 267(9): 2507 doi: 10.1007/s00415-019-09320-1
|
| 277 |
Qihong Liu, Yunfeng Luo, Xiao Ke, Zewei Sun. Interaction between the Gut Microbiota and Intestinal Motility. Evidence-Based Complementary and Alternative Medicine 2022; 2022: 1 doi: 10.1155/2022/3240573
|
| 278 |
B. Bonaz. The gut-brain axis in Parkinson's disease. Revue Neurologique 2024; 180(1-2): 65 doi: 10.1016/j.neurol.2023.11.004
|
| 279 |
Rengasamy Balakrishnan, Shin-Il Kang, Ji-Yeon Lee, Yang-Kook Rho, Byoung-Kook Kim, Dong-Kug Choi. Gut Microbiota-Immune System Interactions in Health and Neurodegenerative Diseases: Insights into Molecular Mechanisms and Therapeutic Applications. Aging and disease 2024; : 0 doi: 10.14336/AD.2024.1362
|
| 280 |
Allison L. Richards, Michael B. Burns, Adnan Alazizi, Luis B. Barreiro, Roger Pique-Regi, Ran Blekhman, Francesca Luca, Jack A. Gilbert. Genetic and Transcriptional Analysis of Human Host Response to Healthy Gut Microbiota. mSystems 2016; 1(4) doi: 10.1128/mSystems.00067-16
|
| 281 |
Kristen D. Pawlowski, Brian T. David, Richard G. Fessler. Spinal Cord–Gut–Immune Axis and Its Implications Regarding Therapeutic Development for Spinal Cord Injury. Journal of Neurotrauma 2023; 40(9-10): 793 doi: 10.1089/neu.2022.0264
|
| 282 |
Sara Ayman Moustafa, Shrouk Mohamed, Abdelhameed Dawood, Jihan Azar, Ekramy Elmorsy, Noura A. M. Rizk, Mohamed Salama. Gut brain axis: an insight into microbiota role in Parkinson’s disease. Metabolic Brain Disease 2021; 36(7): 1545 doi: 10.1007/s11011-021-00808-2
|
| 283 |
Peilin Sun, Lei Su, Hua Zhu, Xue Li, Yaxi Guo, Xiaopeng Du, Ling Zhang, Chuan Qin. Gut Microbiota Regulation and Their Implication in the Development of Neurodegenerative Disease. Microorganisms 2021; 9(11): 2281 doi: 10.3390/microorganisms9112281
|
| 284 |
Adela Ciobanu, Ioana Ionita, Mihaela Buleandra, Iulia David, Dana Popa, Anton Ciucu, Magdalena Budisteanu. Current advances in metabolomic studies on non‑motor psychiatric manifestations of Parkinson's disease (Review). Experimental and Therapeutic Medicine 2021; 22(3) doi: 10.3892/etm.2021.10443
|
| 285 |
Mohd F. Khan, Sugato Banerjee. Comprehensive Gut Microbiota. 2022; : 175 doi: 10.1016/B978-0-12-819265-8.00098-X
|
| 286 |
Saima Khatoon, Nida Kalam, Summya Rashid, Gulnaz Bano. Effects of gut microbiota on neurodegenerative diseases. Frontiers in Aging Neuroscience 2023; 15 doi: 10.3389/fnagi.2023.1145241
|
| 287 |
Julia Doroszkiewicz, Magdalena Groblewska, Barbara Mroczko. The Role of Gut Microbiota and Gut–Brain Interplay in Selected Diseases of the Central Nervous System. International Journal of Molecular Sciences 2021; 22(18): 10028 doi: 10.3390/ijms221810028
|
| 288 |
Laura Mitrea, Silvia-Amalia Nemeş, Katalin Szabo, Bernadette-Emőke Teleky, Dan-Cristian Vodnar. Guts Imbalance Imbalances the Brain: A Review of Gut Microbiota Association With Neurological and Psychiatric Disorders. Frontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.813204
|
| 289 |
Kai Takahashi, Hiroshi Nishiwaki, Mikako Ito, Kazuhiro Iwaoka, Kenta Takahashi, Yoshio Suzuki, Keita Taguchi, Kanako Yamahara, Yoshio Tsuboi, Kenichi Kashihara, Masaaki Hirayama, Kinji Ohno, Tetsuya Maeda. Altered gut microbiota in Parkinson's disease patients with motor complications. Parkinsonism & Related Disorders 2022; 95: 11 doi: 10.1016/j.parkreldis.2021.12.012
|
| 290 |
Weiying Ren, Jiayu Wu, Li Li, Y. Lu, Y. Shao, Y. Qi, B. Xu, Y. He, Yu Hu. Glucagon-Like Peptide-2 Improve Intestinal Mucosal Barrier Function in Aged Rats. The Journal of nutrition, health and aging 2018; 22(6): 731 doi: 10.1007/s12603-018-1022-8
|
| 291 |
George Tetz, Stuart M. Brown, Yuhan Hao, Victor Tetz. Parkinson’s disease and bacteriophages as its overlooked contributors. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-29173-4
|
| 292 |
Agata Mulak. A controversy on the role of short‐chain fatty acids in the pathogenesis of Parkinson's disease. Movement Disorders 2018; 33(3): 398 doi: 10.1002/mds.27304
|
| 293 |
Vincent Caruso, Xubo Song, Mark Asquith, Lisa Karstens, Sean M. Gibbons. Performance of Microbiome Sequence Inference Methods in Environments with Varying Biomass. mSystems 2019; 4(1) doi: 10.1128/msystems.00163-18
|
| 294 |
Agata Mulak. An overview of the neuroendocrine system in Parkinson’s disease: what is the impact on diagnosis and treatment?. Expert Review of Neurotherapeutics 2020; 20(2): 127 doi: 10.1080/14737175.2020.1701437
|
| 295 |
Roger E. Kelley. The Human Hypothalamus. Contemporary Endocrinology 2021; : 479 doi: 10.1007/978-3-030-62187-2_21
|
| 296 |
Sarah K. Lotz, Britanie M. Blackhurst, Katie L. Reagin, Kristen E. Funk. Microbial Infections Are a Risk Factor for Neurodegenerative Diseases. Frontiers in Cellular Neuroscience 2021; 15 doi: 10.3389/fncel.2021.691136
|
| 297 |
Ovidiu-Dumitru Ilie, Alin Ciobica, Jack McKenna, Bogdan Doroftei, Ioannis Mavroudis, Tuane B. Sampaio. Minireview on the Relations between Gut Microflora and Parkinson’s Disease: Further Biochemical (Oxidative Stress), Inflammatory, and Neurological Particularities. Oxidative Medicine and Cellular Longevity 2020; 2020: 1 doi: 10.1155/2020/4518023
|
| 298 |
Young-Ju Kim, Chang-Min Lee, Seongheon Kim, Jae-Won Jang, Seo-Young Lee, Seung-Hwan Lee. Risk of Parkinson’s disease after colectomy: longitudinal follow-up study using a national sample cohort. Journal of Neurology 2020; 267(2): 513 doi: 10.1007/s00415-019-09617-1
|
| 299 |
Dhivya Venkatesan, Mahalaxmi Iyer, Arul Narayanasamy, Kamalakannan Siva, Balachandar Vellingiri. Kynurenine pathway in Parkinson's disease—An update. eNeurologicalSci 2020; 21: 100270 doi: 10.1016/j.ensci.2020.100270
|
| 300 |
Shengzhu Huang, Chenqi Zhang, Xing Xie, Yuanyuan Zhu, Qiong Song, Li Ye, Yan-Ling Hu. GRID2 Aberration Leads to Disturbance in Neuroactive Ligand-Receptor Interaction via Affecting the Species Richness and Composition of the Gut Microbes. SSRN Electronic Journal 2022; doi: 10.2139/ssrn.4133779
|
| 301 |
Sílvia Cabré, Kenneth J. O’Riordan, John F. Cryan. Evolution, Biodiversity and a Reassessment of the Hygiene Hypothesis. Progress in Inflammation Research 2022; 89: 339 doi: 10.1007/978-3-030-91051-8_11
|
| 302 |
Rafael Franco, Rafael Rivas-Santisteban, Irene Reyes-Resina, Gemma Navarro, Eva Martínez-Pinilla. Microbiota and Other Preventive Strategies and Non-genetic Risk Factors in Parkinson’s Disease. Frontiers in Aging Neuroscience 2020; 12 doi: 10.3389/fnagi.2020.00012
|
| 303 |
Sinian Li, Yiming Shao, Kanglan Li, Changmei HuangFu, Wenjie Wang, Zhou Liu, Zhiyou Cai, Bin Zhao. Vascular Cognitive Impairment and the Gut Microbiota. Journal of Alzheimer's Disease 2018; 63(4): 1209 doi: 10.3233/JAD-171103
|
| 304 |
Ketil Berstad, Johanna E.R. Berstad. Parkinson’s disease; the hibernating spore hypothesis. Medical Hypotheses 2017; 104: 48 doi: 10.1016/j.mehy.2017.05.022
|
| 305 |
Donatella Tesei, Anna Jewczynko, Anne Lynch, Camilla Urbaniak. Understanding the Complexities and Changes of the Astronaut Microbiome for Successful Long-Duration Space Missions. Life 2022; 12(4): 495 doi: 10.3390/life12040495
|
| 306 |
Jing Liu, Fei Xu, Zhiyan Nie, Lei Shao. Gut Microbiota Approach—A New Strategy to Treat Parkinson’s Disease. Frontiers in Cellular and Infection Microbiology 2020; 10 doi: 10.3389/fcimb.2020.570658
|
| 307 |
Wenyu Dai, Jieyu Liu, Yan Qiu, Ziwei Teng, Sujuan Li, Hui Yuan, Jing Huang, Hui Xiang, Hui Tang, Bolun Wang, Jindong Chen, Haishan Wu. Gut Microbial Dysbiosis and Cognitive Impairment in Bipolar Disorder: Current Evidence. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.893567
|
| 308 |
Xin Wang, Deming Jiang, Tianxiong Li, Xiao Zhang, Ran Wang, Song Gao, Fengyi Yang, Yan Wang, Qi Tian, Chunrong Xie, Jinghong Liang. Association between microbiological risk factors and neurodegenerative disorders: An umbrella review of systematic reviews and meta-analyses. Frontiers in Psychiatry 2022; 13 doi: 10.3389/fpsyt.2022.991085
|
| 309 |
Ying Dong, Pan Wang, Junling Lin, Chunming Han, Jie Jiao, Kun Zuo, Mulei Chen, Xinchun Yang, Jun Cai, He Jiang, Xiheng Guo, Jing Li. Characterization of fecal metabolome changes in patients with obstructive sleep apnea. Journal of Clinical Sleep Medicine 2022; 18(2): 575 doi: 10.5664/jcsm.9668
|
| 310 |
Kelly Jimin Park, Yao Gao. Gut-brain axis and neurodegeneration: mechanisms and therapeutic potentials. Frontiers in Neuroscience 2024; 18 doi: 10.3389/fnins.2024.1481390
|
| 311 |
V. Andreozzi, S. Cuoco, M. Balestrieri, F. Fierro, N. Ferrara, R. Erro, M. Di Filippo, G. Barbella, M. C. Memoli, A. Silvestri, M. Squillante, S. Guglielmetti, P. Barone, P. Iovino, M. T. Pellecchia. Synbiotic supplementation may globally improve non-motor symptoms in patients with stable Parkinson’s disease: results from an open label single-arm study. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-74400-w
|
| 312 |
R. R. Tyutina, A. A. Pilipovich, V. L. Golubev, Al. B. Danilov. Microbiota and Parkinson's disease (overview). Medical alphabet 2020; (1): 10 doi: 10.33667/2078-5631-2020-1-10-14
|
| 313 |
Salvatore Bonvegna, Roberto Cilia. Precision Medicine in Neurodegenerative Disorders, Part II. Handbook of Clinical Neurology 2023; 193: 107 doi: 10.1016/B978-0-323-85555-6.00006-0
|
| 314 |
Kurt A. Jellinger. Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update—I. Hypokinetic-rigid movement disorders. Journal of Neural Transmission 2019; 126(8): 933 doi: 10.1007/s00702-019-02028-6
|
| 315 |
Soumya Sundaram, Dinoop Korol Ponnambath, Sruthi S. Nair. Human Microbiome. 2022; : 147 doi: 10.1007/978-981-16-7672-7_7
|
| 316 |
Natasa Kustrimovic, Sahar Balkhi, Giorgia Bilato, Lorenzo Mortara. Gut Microbiota and Immune System Dynamics in Parkinson’s and Alzheimer’s Diseases. International Journal of Molecular Sciences 2024; 25(22): 12164 doi: 10.3390/ijms252212164
|
| 317 |
Wei Qin, Yirong Shi, Weimei Chen, Xiaokang Jia, Tetsuya Asakawa. Can kynurenine pathway be considered as a next-generation therapeutic target for Parkinson's disease? An update information. BioScience Trends 2022; 16(4): 249 doi: 10.5582/bst.2022.01352
|
| 318 |
Yiwei Qian, Xiaodong Yang, Shaoqing Xu, Chunyan Wu, Nan Qin, Sheng-Di Chen, Qin Xiao. Detection of Microbial 16S rRNA Gene in the Blood of Patients With Parkinson’s Disease. Frontiers in Aging Neuroscience 2018; 10 doi: 10.3389/fnagi.2018.00156
|
| 319 |
Guadalupe Vidal-Martinez, Brandon Chin, Cynthia Camarillo, Gloria V. Herrera, Barbara Yang, Irene Sarosiek, Ruth G. Perez. A Pilot Microbiota Study in Parkinson’s Disease Patients versus Control Subjects, and Effects of FTY720 and FTY720-Mitoxy Therapies in Parkinsonian and Multiple System Atrophy Mouse Models. Journal of Parkinson’s Disease 2019; 10(1): 185 doi: 10.3233/JPD-191693
|
| 320 |
Madelyn C. Houser, Malú G. Tansey. The gut-brain axis: is intestinal inflammation a silent driver of Parkinson’s disease pathogenesis?. npj Parkinson's Disease 2017; 3(1) doi: 10.1038/s41531-016-0002-0
|
| 321 |
Xianmin Lu, Qi Liu, Ya Deng, Jiangbo Wu, Xingyi Mu, Xiaoxu Yang, Ting Zhang, Chen Luo, Zhuo Li, Siqi Tang, Yanxia Hu, Qian Du, Jingyu Xu, Rui Xie. Research progress on the roles of dopamine and dopamine receptors in digestive system diseases. Journal of Cellular and Molecular Medicine 2024; 28(7) doi: 10.1111/jcmm.18154
|
| 322 |
Shuo Yang, Xiaojia Sun, Dianfeng Liu, Yiming Zhang, Xiyu Gao, Jiangmei He, Mingchi Cui, Shoupeng Fu, Dewei He. Allantoin ameliorates dopaminergic neuronal damage in MPTP-induced Parkinson's disease mice via regulating oxidative damage, inflammation, and gut microbiota disorder. Food & Function 2024; 15(18): 9390 doi: 10.1039/D4FO02167C
|
| 323 |
Jacek Baj, Alicja Forma, Wojciech Flieger, Izabela Morawska, Adam Michalski, Grzegorz Buszewicz, Elżbieta Sitarz, Piero Portincasa, Gabriella Garruti, Michał Flieger, Grzegorz Teresiński. Helicobacter pylori Infection and Extragastric Diseases—A Focus on the Central Nervous System. Cells 2021; 10(9): 2191 doi: 10.3390/cells10092191
|
| 324 |
Hongxiang Zhao, Meiyan Sun, Yue Zhang, Wenwen Kong, Lulu Fan, Kaifang Wang, Qing Xu, Baiyan Chen, Jianxin Dong, Yanan Shi, Zhengyan Wang, ShiQi Wang, Xiaoli Zhuang, Qi Li, Feihong Lin, Xinyu Yao, WenBo Zhang, Chang Kong, Rui Zhang, Dayun Feng, Xiaoyong Zhao. Connecting the Dots: The Cerebral Lymphatic System as a Bridge Between the Central Nervous System and Peripheral System in Health and Disease. Aging and disease 2024; 15(1): 115 doi: 10.14336/AD.2023.0516
|
| 325 |
Yanpei Huang, Haiming Chen, Weijun Chen, Wenxue Chen, Qiuping Zhong, Jianfei Pei, Ming Zhang, Guido R. M. M. Haenen. Development and Application of Polyphenols in Food: A Comprehensive Review. Food Frontiers 2025; doi: 10.1002/fft2.533
|
| 326 |
Priya Bindal, Swati Kaushal, Charan Singh, Arti Singh. Microbiota-Gut-Brain Axis and CNS Disorders. 2025; : 111 doi: 10.1016/B978-0-443-21680-0.00005-5
|
| 327 |
Wu Zhou, Lihong Zhao, Zelu Mao, Zhihua Wang, Zhixiong Zhang, Meihua Li. Bidirectional Communication Between the Brain and Other Organs: The Role of Extracellular Vesicles. Cellular and Molecular Neurobiology 2023; 43(6): 2675 doi: 10.1007/s10571-023-01345-5
|
| 328 |
Yaoyu Pu, Lijia Chang, Youge Qu, Siming Wang, Kai Zhang, Kenji Hashimoto. Antibiotic-induced microbiome depletion protects against MPTP-induced dopaminergic neurotoxicity in the brain. Aging 2019; 11(17): 6915 doi: 10.18632/aging.102221
|
| 329 |
Shakshi Sharma, Anupam Awasthi, Shamsher Singh. Altered gut microbiota and intestinal permeability in Parkinson’s disease: Pathological highlight to management. Neuroscience Letters 2019; 712: 134516 doi: 10.1016/j.neulet.2019.134516
|
| 330 |
Li-song Zhu, Jing Wang, Jun Lu, Hui-qian Liu, Xiao-qing Jin, Zhen-yu Shu, Li-hong Li. Effect of hemodynamic characteristic changes of the carotid artery on 6-OHDA-induced Parkinson’s disease model rats treated by Gut-acupuncture. Journal of King Saud University - Science 2020; 32(6): 2675 doi: 10.1016/j.jksus.2020.03.038
|
| 331 |
Xi Jia, Qin Wang, Meilingzi Liu, Jia-yuan Ding. The interplay between gut microbiota and the brain-gut axis in Parkinson’s disease treatment. Frontiers in Neurology 2024; 15 doi: 10.3389/fneur.2024.1415463
|
| 332 |
Suzanne T. Witt, Olga Bednarska, Åsa V. Keita, Adriane Icenhour, Michael P. Jones, Sigrid Elsenbruch, Johan D. Söderholm, Maria Engström, Emeran A. Mayer, Susanna Walter. Interactions between gut permeability and brain structure and function in health and irritable bowel syndrome. NeuroImage: Clinical 2019; 21: 101602 doi: 10.1016/j.nicl.2018.11.012
|
| 333 |
Xin Xie, Xiaoguang Luo, Mingliang Xie. Association between Parkinson's disease and risk of colorectal cancer. Parkinsonism & Related Disorders 2017; 35: 42 doi: 10.1016/j.parkreldis.2016.11.011
|
| 334 |
Fenfa Li, Xichun Peng, Wenzhi Li. The interaction between various food components and intestinal microbiota improves human health through the gut–X axis: independently or synergistically. Food & Function 2025; 16(6): 2172 doi: 10.1039/D4FO04430D
|
| 335 |
Jinglu Hu, Wencheng Jiao, Ziyan Tang, Chunqing Wang, Qi Li, Meng Wei, Shiyong Song, Lina Du, Yiguang Jin. Quercetin inclusion complex gels ameliorate radiation-induced brain injury by regulating gut microbiota. Biomedicine & Pharmacotherapy 2023; 158: 114142 doi: 10.1016/j.biopha.2022.114142
|
| 336 |
Michael Ganci, Emra Suleyman, Henry Butt, Michelle Ball. The role of the brain–gut–microbiota axis in psychology: The importance of considering gut microbiota in the development, perpetuation, and treatment of psychological disorders. Brain and Behavior 2019; 9(11) doi: 10.1002/brb3.1408
|
| 337 |
Lan Yu, Xiaolu Hu, Rongrong Xu, Yimeng Zhao, Lijuan Xiong, Jiaxuan Ai, Xing Wang, Xiaoqing Chen, Yinying Ba, Zhikai Xing, Chongye Guo, Shuangli Mi, Xia Wu. Piperine promotes PI3K/AKT/mTOR-mediated gut-brain autophagy to degrade α-Synuclein in Parkinson’s disease rats. Journal of Ethnopharmacology 2024; 322: 117628 doi: 10.1016/j.jep.2023.117628
|
| 338 |
Cesar de la Fuente-Nunez, Beatriz Torres Meneguetti, Octávio Luiz Franco, Timothy K. Lu. Neuromicrobiology: How Microbes Influence the Brain. ACS Chemical Neuroscience 2018; 9(2): 141 doi: 10.1021/acschemneuro.7b00373
|
| 339 |
Cai-xia Gong, Cheng Ma, Dejene Disasa Irge, Shu-min Li, Si-min Chen, Shi-xian Zhou, Xin-xiu Zhao, Han-yu Li, Jin-you Li, Yun-mei Yang, Lan Xiang, Qin Zhang. Gastrodia elata and parishin ameliorate aging induced ‘leaky gut’ in mice: Correlation with gut microbiota. Biomedical Journal 2023; 46(4): 100547 doi: 10.1016/j.bj.2022.07.001
|
| 340 |
Nina Gorlé, Eva Bauwens, Freddy Haesebrouck, Annemieke Smet, Roosmarijn E. Vandenbroucke. Helicobacter and the Potential Role in Neurological Disorders: There Is More Than Helicobacter pylori. Frontiers in Immunology 2021; 11 doi: 10.3389/fimmu.2020.584165
|
| 341 |
Małgorzata Anna Marć, Rafał Jastrząb, Jennifer Mytych. Does the Gut Microbial Metabolome Really Matter? The Connection between GUT Metabolome and Neurological Disorders. Nutrients 2022; 14(19): 3967 doi: 10.3390/nu14193967
|
| 342 |
Jun-Ji Cui, Ze-Yun Huang, Yi-Hang Xie, Jun-Bin Wu, Guang-Hui Xu, Cheng-Fu Li, Man-Man Zhang, Li-Tao Yi. Gut microbiota mediated inflammation, neuroendocrine and neurotrophic functions involved in the antidepressant-like effects of diosgenin in chronic restraint stress. Journal of Affective Disorders 2023; 321: 242 doi: 10.1016/j.jad.2022.10.045
|
| 343 |
Florina Ruța, Mirela Pribac, Elena Mardale, Sara Suciu, Raluca Maior, Simona Bogdan, Călin Avram. Associations between Gut Microbiota Dysbiosis and Other Risk Factors in Women with a History of Urinary Tract Infections. Nutrients 2024; 16(11): 1753 doi: 10.3390/nu16111753
|
| 344 |
F. Khan, S.F. Oloketuyi. A future perspective on neurodegenerative diseases: nasopharyngeal and gut microbiota. Journal of Applied Microbiology 2017; 122(2): 306 doi: 10.1111/jam.13327
|
| 345 |
David J. McGee, Xiao-Hong Lu, Elizabeth A. Disbrow. Stomaching the Possibility of a Pathogenic Role for Helicobacter pylori in Parkinson’s Disease. Journal of Parkinson’s Disease 2018; 8(3): 367 doi: 10.3233/JPD-181327
|
| 346 |
Shirley H. F. Lee, Siti R. Ahmad, Ya C. Lim, Ihsan N. Zulkipli. The Use of Probiotic Therapy in Metabolic and Neurological Diseases. Frontiers in Nutrition 2022; 9 doi: 10.3389/fnut.2022.887019
|
| 347 |
Simona Cannas, Barbara Tonini, Benedetta Belà, Roberta Di Prinzio, Giulia Pignataro, Daniele Di Simone, Alessandro Gramenzi. Effect of a novel nutraceutical supplement (Relaxigen Pet dog) on the fecal microbiome and stress-related behaviors in dogs: A pilot study. Journal of Veterinary Behavior 2021; 42: 37 doi: 10.1016/j.jveb.2020.09.002
|
| 348 |
Rehab E. Abo El Gheit, Marwa M. Atef, Omnia S. El Deeb, Ghada A. Badawi, Hanan A. Alshenawy, Walaa M. Elwan, Heba M. Arakeep, Marwa N. Emam. Unique Novel Role of Adropin in a Gastric Ulcer in a Rotenone-Induced Rat Model of Parkinson’s Disease. ACS Chemical Neuroscience 2020; 11(19): 3077 doi: 10.1021/acschemneuro.0c00424
|
| 349 |
Monica Barone, Federica D’Amico, Simone Rampelli, Patrizia Brigidi, Silvia Turroni. Age-related diseases, therapies and gut microbiome: A new frontier for healthy aging. Mechanisms of Ageing and Development 2022; 206: 111711 doi: 10.1016/j.mad.2022.111711
|
| 350 |
Jiangjiang Bi, Yifan Xu, Shiyong Li, Gaofeng Zhan, Dongyu Hua, Juan Tan, Xiaohui Chi, Hongbing Xiang, Fengjing Guo, Ailin Luo. Contribution of preoperative gut microbiota in postoperative neurocognitive dysfunction in elderly patients undergoing orthopedic surgery. Frontiers in Aging Neuroscience 2023; 15 doi: 10.3389/fnagi.2023.1108205
|
| 351 |
Suparna Roy Sarkar, Sugato Banerjee. Gut microbiota in neurodegenerative disorders. Journal of Neuroimmunology 2019; 328: 98 doi: 10.1016/j.jneuroim.2019.01.004
|
| 352 |
Marcela Konjevod, Matea Nikolac Perkovic, Jorge Sáiz, Dubravka Svob Strac, Coral Barbas, David Rojo. Metabolomics analysis of microbiota-gut-brain axis in neurodegenerative and psychiatric diseases. Journal of Pharmaceutical and Biomedical Analysis 2021; 194: 113681 doi: 10.1016/j.jpba.2020.113681
|
| 353 |
Yusra Habib Khan, Aroosa Liaqat, Tauqeer Hussain Mallhi, Arooj Abid, Nasser Hadal Alotaibi, Amjad Khan. Environmental Contaminants and Neurological Disorders. Emerging Contaminants and Associated Treatment Technologies 2021; : 49 doi: 10.1007/978-3-030-66376-6_3
|
| 354 |
Henry B. Ogden, Joanne L. Fallowfield, Robert B. Child, Glen Davison, Simon C. Fleming, Robert M. Edinburgh, Simon K. Delves, Alison Millyard, Caroline S. Westwood, Joseph D. Layden. Reliability of gastrointestinal barrier integrity and microbial translocation biomarkers at rest and following exertional heat stress. Physiological Reports 2020; 8(5) doi: 10.14814/phy2.14374
|
| 355 |
Alexander M. Vaiserman, Alexander K. Koliada, Francesco Marotta. Gut microbiota: A player in aging and a target for anti-aging intervention. Ageing Research Reviews 2017; 35: 36 doi: 10.1016/j.arr.2017.01.001
|
| 356 |
Xiaoyu Zhang, Jia Wang, Tingting Zhang, Shuqin Li, Junyu Liu, Mingyue Li, Jingyang Lu, Min Zhang, Haixia Chen. Updated Progress on Polysaccharides with Anti-Diabetic Effects through the Regulation of Gut Microbiota: Sources, Mechanisms, and Structure–Activity Relationships. Pharmaceuticals 2024; 17(4): 456 doi: 10.3390/ph17040456
|
| 357 |
Ning Xu, Shuyang Xing, Jie Li, Bo Pang, Meichen Liu, Meiling Fan, Yu Zhao, Chun-Hua Wang. Water extract of ginseng alleviates parkinsonism in MPTP–induced Parkinson’s disease mice. PLOS ONE 2024; 19(9): e0296424 doi: 10.1371/journal.pone.0296424
|
| 358 |
Antonio Di Sabatino, Marco Vincenzo Lenti, Lisa Cammalleri, Gino Roberto Corazza, Alberto Pilotto. Frailty and the gut. Digestive and Liver Disease 2018; 50(6): 533 doi: 10.1016/j.dld.2018.03.010
|
| 359 |
Ingrid Rivera-Iñiguez, Sonia Roman, Claudia Ojeda-Granados, Panduro Arturo. Microbiome and Metabolome in Diagnosis, Therapy, and other Strategic Applications. 2019; : 379 doi: 10.1016/B978-0-12-815249-2.00040-3
|
| 360 |
Sonia González, Nuria Salazar, Sergio Ruiz-Saavedra, María Gómez-Martín, Clara G. de los Reyes-Gavilán, Miguel Gueimonde. Long-Term Coffee Consumption is Associated with Fecal Microbial Composition in Humans. Nutrients 2020; 12(5): 1287 doi: 10.3390/nu12051287
|
| 361 |
Gábor Ternák, Károly Berényi, Balázs Németh, Ágnes Szenczi, Gergely Márovics, István Kiss. Association of antibiotic-consumption patterns with the prevalence of hematological malignancies in European countries. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-11569-y
|
| 362 |
Qiang Yue, Mingfei Cai, Bo Xiao, Qiong Zhan, Chang Zeng. The Microbiota–Gut–Brain Axis and Epilepsy. Cellular and Molecular Neurobiology 2022; 42(2): 439 doi: 10.1007/s10571-021-01130-2
|
| 363 |
Mohamed J. Saadh, Anfal Nabeel Mustafa, Mohammed Ahmed Mustafa, Renuka Jyothi. S, Hasan Khalid Dabis, G. V. Siva Prasad, Imad Jassim Mohammad, Ahmed Adnan, Ameer Hassan Idan. The role of gut-derived short-chain fatty acids in Parkinson's disease. Neurogenetics 2024; 25(4): 307 doi: 10.1007/s10048-024-00779-3
|
| 364 |
Saravana Babu Chidambaram, Annan Gopinath Rathipriya, Arehally M. Mahalakshmi, Sonali Sharma, Tousif Ahmed Hediyal, Bipul Ray, Tuladhar Sunanda, Wiramon Rungratanawanich, Rajpal Singh Kashyap, M. Walid Qoronfleh, Musthafa Mohamed Essa, Byoung-Joon Song, Tanya M. Monaghan. The Influence of Gut Dysbiosis in the Pathogenesis and Management of Ischemic Stroke. Cells 2022; 11(7): 1239 doi: 10.3390/cells11071239
|
| 365 |
G. B. Stefano, N. Pilonis, R. Ptacek, J. Raboch, M. Vnukova, R. M. Kream. Gut, Microbiome, and Brain Regulatory Axis: Relevance to Neurodegenerative and Psychiatric Disorders. Cellular and Molecular Neurobiology 2018; 38(6): 1197 doi: 10.1007/s10571-018-0589-2
|
| 366 |
Yaqi Xue, Shasha An, Weihua Qiu, Weinan Zhang, Limin Fu, Zhiping Zhen. Exercise Changes Gut Microbiota: A New Idea to Explain that Exercise
Improves Autism. International Journal of Sports Medicine 2023; 44(07): 473 doi: 10.1055/a-2018-2477
|
| 367 |
Vittorio Calabrese, Aurelia Santoro, Daniela Monti, Rosalia Crupi, Rosanna Di Paola, Saverio Latteri, Salvatore Cuzzocrea, Mario Zappia, James Giordano, Edward J. Calabrese, Claudio Franceschi. Aging and Parkinson's Disease: Inflammaging, neuroinflammation and biological remodeling as key factors in pathogenesis. Free Radical Biology and Medicine 2018; 115: 80 doi: 10.1016/j.freeradbiomed.2017.10.379
|
| 368 |
Audrey Labarre, Ericka Guitard, Gilles Tossing, Anik Forest, Eric Bareke, Marjorie Labrecque, Martine Tétreault, Matthieu Ruiz, J. Alex Parker. Fatty acids derived from the probiotic Lacticaseibacillus rhamnosus HA-114 suppress age-dependent neurodegeneration. Communications Biology 2022; 5(1) doi: 10.1038/s42003-022-04295-8
|
| 369 |
Shuyuan Guo, Zhuxia Zhang, Bingxuan Xu, Mengxin Wang, Taojian Fan, Xinliang Zhong, Azhen Hu, Die Hu, Lan Luo, Shuping Lin, Linlin Wang, Rongquan Yao, Jiabao Huang, Huiying Hu, Xintao Shuai, Jie Shi, Yun Chen, Tingting Zheng. Black Phosphorus Microbubbles Combined with Ultrasound for Treating Parkinson's Disease. Advanced Therapeutics 2024; 7(5) doi: 10.1002/adtp.202300254
|
| 370 |
Tapan Behl, Ishnoor Kaur, Aayush Sehgal, Sukhbir Singh, Saurabh Bhatia, Ahmed Al-Harrasi, Gokhan Zengin, Adrian Gheorghe Bumbu, Felicia Liana Andronie-Cioara, Aurelia Cristina Nechifor, Daniela Gitea, Alexa Florina Bungau, Mirela Marioara Toma, Simona Gabriela Bungau. The Footprint of Kynurenine Pathway in Neurodegeneration: Janus-Faced Role in Parkinson’s Disorder and Therapeutic Implications. International Journal of Molecular Sciences 2021; 22(13): 6737 doi: 10.3390/ijms22136737
|
| 371 |
Li Liu, Xiaodong Liu. Drug Transporters in Drug Disposition, Effects and Toxicity. Advances in Experimental Medicine and Biology 2019; 1141: 407 doi: 10.1007/978-981-13-7647-4_9
|
| 372 |
Natalia Palacios, Katherine C. Hughes, Emanuele Cereda, Michael A. Schwarzschild, Alberto Ascherio. Appendectomy and risk of Parkinson's disease in two large prospective cohorts of men and women. Movement Disorders 2018; 33(9): 1492 doi: 10.1002/mds.109
|
| 373 |
Xiaodong Yang, Yiwei Qian, Shaoqing Xu, Yanyan Song, Qin Xiao. Longitudinal Analysis of Fecal Microbiome and Pathologic Processes in a Rotenone Induced Mice Model of Parkinson’s Disease. Frontiers in Aging Neuroscience 2018; 9 doi: 10.3389/fnagi.2017.00441
|
| 374 |
Xue Ma, Qiang Wang, Wei Yuan, Yuan Wang, Feng Zhou, Kaiwen Kang, Xiaopeng Tong, Zhibin Liu. Electroacupuncture Alleviates Neuroinflammation and Motor Dysfunction by Regulating Intestinal Barrier Function in a Mouse Model of Parkinson Disease. Journal of Neuropathology & Experimental Neurology 2021; 80(9): 844 doi: 10.1093/jnen/nlab046
|
| 375 |
Zhongci Hang, Tong Lei, Zehua Zeng, Shanglin Cai, Wangyu Bi, Hongwu Du. Composition of intestinal flora affects the risk relationship between Alzheimer's disease/Parkinson's disease and cancer. Biomedicine & Pharmacotherapy 2022; 145: 112343 doi: 10.1016/j.biopha.2021.112343
|
| 376 |
Hong‐Xia Fan, Shuo Sheng, Feng Zhang. New hope for Parkinson's disease treatment: Targeting gut microbiota. CNS Neuroscience & Therapeutics 2022; 28(11): 1675 doi: 10.1111/cns.13916
|
| 377 |
L. Sardelli, M. Campanile, L. Boeri, F. Donnaloja, F. Fanizza, S. Perottoni, P. Petrini, D. Albani, C. Giordano. A novel on-a-chip system with a 3D-bioinspired gut mucus suitable to investigate bacterial endotoxins dynamics. Materials Today Bio 2024; 24: 100898 doi: 10.1016/j.mtbio.2023.100898
|
| 378 |
Ruby Sound. Nutraceuticals in Brain Health and Beyond. 2021; : 175 doi: 10.1016/B978-0-12-820593-8.00013-6
|
| 379 |
Nidhi Singh, Veer Singh, Sachchida Nand Rai, Vishal Mishra, Emanuel Vamanu, Mohan P. Singh. Deciphering the gut microbiome in neurodegenerative diseases and metagenomic approaches for characterization of gut microbes. Biomedicine & Pharmacotherapy 2022; 156: 113958 doi: 10.1016/j.biopha.2022.113958
|
| 380 |
Xiaoge Sun, Manish Shukla, Wei Wang, Shengli Li. Unlocking gut-liver-brain axis communication metabolites: energy metabolism, immunity and barriers. npj Biofilms and Microbiomes 2024; 10(1) doi: 10.1038/s41522-024-00610-9
|
| 381 |
Tsuyoshi Miyaoka, Misako Kanayama, Rei Wake, Sadayuki Hashioka, Maiko Hayashida, Michiharu Nagahama, Shihoh Okazaki, Satoko Yamashita, Shoko Miura, Hiroyuki Miki, Hiroyuki Matsuda, Masahiro Koike, Muneto Izuhara, Tomoko Araki, Keiko Tsuchie, Ilhamuddin Abdul Azis, Ryosuke Arauchi, Rostia Arianna Abdullah, Arata Oh-Nishi, Jun Horiguchi. Clostridium butyricum MIYAIRI 588 as Adjunctive Therapy for Treatment-Resistant Major Depressive Disorder: A Prospective Open-Label Trial. Clinical Neuropharmacology 2018; 41(5): 151 doi: 10.1097/WNF.0000000000000299
|
| 382 |
Christina Kumpitsch, Kaisa Koskinen, Veronika Schöpf, Christine Moissl-Eichinger. The microbiome of the upper respiratory tract in health and disease. BMC Biology 2019; 17(1) doi: 10.1186/s12915-019-0703-z
|
| 383 |
Mohamed J. Saadh, Shahad Mohammed Dhiaa, Pooja Bansal, Hasan Khalid Dabis, Ashu Katyal, Vivek Saraswat, Azher Abdulmutaleb Ibrahim, Radi Usama Kadem, Mohammed Ubaid. The Role of Gut Microbiota-derived Short Chain Fatty Acids in Amyotrophic Lateral Sclerosis. Current Behavioral Neuroscience Reports 2025; 12(1) doi: 10.1007/s40473-024-00292-9
|
| 384 |
Hang Zhu, Guifen Xu. Electrochemical biosensors for dopamine. Clinica Chimica Acta 2025; 566: 120039 doi: 10.1016/j.cca.2024.120039
|
| 385 |
Ramdas Mane, Saurabh Kashid, Farhan Mazahir, Awesh Kumar Yadav. Microbiota-Gut-Brain Axis and CNS Disorders. 2025; : 441 doi: 10.1016/B978-0-443-21680-0.00019-5
|
| 386 |
Bojing Liu, Arvid Sjölander, Nancy L. Pedersen, Jonas F. Ludvigsson, Honglei Chen, Fang Fang, Karin Wirdefeldt. Irritable bowel syndrome and Parkinson’s disease risk: register-based studies. npj Parkinson's Disease 2021; 7(1) doi: 10.1038/s41531-020-00145-8
|
| 387 |
Agata Mulak, Magdalena Koszewicz, Magdalena Panek-Jeziorna, Ewa Koziorowska-Gawron, Sławomir Budrewicz. Fecal Calprotectin as a Marker of the Gut Immune System Activation Is Elevated in Parkinson’s Disease. Frontiers in Neuroscience 2019; 13 doi: 10.3389/fnins.2019.00992
|
| 388 |
Tsung-Hsun Hsieh, Chi-Wei Kuo, Kai-Hsuan Hsieh, Meng-Jyh Shieh, Chih-Wei Peng, Yen-Chien Chen, Ying-Ling Chang, Ying-Zu Huang, Chih-Chung Chen, Pi-Kai Chang, Kai-Yun Chen, Hsin-Yung Chen. Probiotics Alleviate the Progressive Deterioration of Motor Functions in a Mouse Model of Parkinson’s Disease. Brain Sciences 2020; 10(4): 206 doi: 10.3390/brainsci10040206
|
| 389 |
Zeyu Bao, Zeyu Zhang, Guoyang Zhou, Anke Zhang, Anwen Shao, Feng Zhou. Novel Mechanisms and Therapeutic Targets for Ischemic Stroke: A Focus on Gut Microbiota. Frontiers in Cellular Neuroscience 2022; 16 doi: 10.3389/fncel.2022.871720
|
| 390 |
Dragos Mihaila, Jordan Donegan, Sarah Barns, Daria LaRocca, Qian Du, Danny Zheng, Michael Vidal, Christopher Neville, Richard Uhlig, Frank A. Middleton, Brenda A Wilson. The oral microbiome of early stage Parkinson’s disease and its relationship with functional measures of motor and non-motor function. PLOS ONE 2019; 14(6): e0218252 doi: 10.1371/journal.pone.0218252
|
| 391 |
Paula Perez-Pardo, Tessa Kliest, Hemraj B. Dodiya, Laus M. Broersen, Johan Garssen, Ali Keshavarzian, Aletta D. Kraneveld. The gut-brain axis in Parkinson's disease: Possibilities for food-based therapies. European Journal of Pharmacology 2017; 817: 86 doi: 10.1016/j.ejphar.2017.05.042
|
| 392 |
Parisa Gazerani. Probiotics for Parkinson’s Disease. International Journal of Molecular Sciences 2019; 20(17): 4121 doi: 10.3390/ijms20174121
|
| 393 |
Chunmei Jiang, Guangning Li, Pengru Huang, Zhou Liu, Bin Zhao. The Gut Microbiota and Alzheimer’s Disease. Journal of Alzheimer's Disease 2017; 58(1): 1 doi: 10.3233/JAD-161141
|
| 394 |
Szu-Ju Chen, Yu-Chiao Chi, Chang-Han Ho, Wei-Shiung Yang, Chin-Hsien Lin. Plasma Lipopolysaccharide-Binding Protein Reflects Risk and Progression of Parkinson’s Disease. Journal of Parkinson's Disease 2021; 11(3): 1129 doi: 10.3233/JPD-212574
|
| 395 |
Yaping Shao, Weidong Le. Recent advances and perspectives of metabolomics-based investigations in Parkinson’s disease. Molecular Neurodegeneration 2019; 14(1) doi: 10.1186/s13024-018-0304-2
|
| 396 |
Ali Rezaie, Satish S.C. Rao. Handbook of Gastrointestinal Motility and Disorders of Gut-Brain Interactions. 2023; : 205 doi: 10.1016/B978-0-443-13911-6.00015-3
|
| 397 |
Shiro Mawatari, Yasuhiro Sasuga, Tomomi Morisaki, Mika Okubo, Takako Emura, Takehiko Fujino. Identification of plasmalogens in Bifidobacterium longum, but not in Bifidobacterium animalis. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-019-57309-7
|
| 398 |
Yunxin Hu, Haoyue Wang, Yongkang Zhong, Yongqi Sun. Retrospective analysis of diet and gut microbiota diversity and clinical pharmacology outcomes in patients with Parkinsonism syndrome. Heliyon 2024; 10(21): e38645 doi: 10.1016/j.heliyon.2024.e38645
|
| 399 |
Ziying Jiang, Xinyu Wang, Haoqiang Zhang, Jian Yin, Peiqing Zhao, Qingqing Yin, Zhenfu Wang. Ketogenic diet protects MPTP‐induced mouse model of Parkinson's disease via altering gut microbiota and metabolites. MedComm 2023; 4(3) doi: 10.1002/mco2.268
|
| 400 |
Bushra Bashir, Shahbaz Alam, Nikhil Khandale, Devendra Birla, Sukriti Vishwas, Narendra Kumar Pandey, Gaurav Gupta, Keshav Raj Paudel, Harish Dureja, Puneet Kumar, Thakur Gurjeet Singh, Gowthamarajan Kuppusamy, Flavia C. Zacconi, Terezinha de Jesus Andreoli Pinto, Muralikrishnan Dhanasekaran, Monica Gulati, Kamal Dua, Sachin Kumar Singh. Opening avenues for treatment of neurodegenerative disease using post-biotics: Breakthroughs and bottlenecks in clinical translation. Ageing Research Reviews 2024; 95: 102236 doi: 10.1016/j.arr.2024.102236
|
| 401 |
Yongtao He, Jiayin Zhao, Hongtian Dong, Xiaoshuang Zhang, Yufei Duan, Yuanyuan Ma, Mei Yu, Jian Fei, Fang Huang. TLR2 deficiency is beneficial at the late phase in MPTP-induced Parkinson’ disease mice. Life Sciences 2023; 333: 122171 doi: 10.1016/j.lfs.2023.122171
|
| 402 |
Gizem Özata UYAR, Hilal YILDIRAN. A nutritional approach to microbiota in Parkinson’s disease. Bioscience of Microbiota, Food and Health 2019; 38(4): 115 doi: 10.12938/bmfh.19-002
|
| 403 |
Kathleen Shannon, Pieter Vanden Berghe. The enteric nervous system in PD: gateway, bystander victim, or source of solutions. Cell and Tissue Research 2018; 373(1): 313 doi: 10.1007/s00441-018-2856-4
|
| 404 |
Zhe Zhao, Fangyuan Li, Jingwen Ning, Ran Peng, Junmei Shang, Hui Liu, Meiyu Shang, Xiu-Qi Bao, Dan Zhang. Novel compound FLZ alleviates rotenone-induced PD mouse model by suppressing TLR4/MyD88/NF-κB pathway through microbiota–gut–brain axis. Acta Pharmaceutica Sinica B 2021; 11(9): 2859 doi: 10.1016/j.apsb.2021.03.020
|
| 405 |
Urdhva Raval, Joyce M. Harary, Emma Zeng, Giulio M. Pasinetti. The dichotomous role of the gut microbiome in exacerbating and ameliorating neurodegenerative disorders. Expert Review of Neurotherapeutics 2020; 20(7): 673 doi: 10.1080/14737175.2020.1775585
|
| 406 |
Xiao-Li Dong, Xiong Wang, Fang Liu, Xin Liu, Zhong-Rui Du, Robert.W. Li, Chang-Hu Xue, Ka-Hing Wong, Wing-Tak Wong, Qing Zhao, Qing-Juan Tang. Polymannuronic acid prevents dopaminergic neuronal loss via brain-gut-microbiota axis in Parkinson's disease model. International Journal of Biological Macromolecules 2020; 164: 994 doi: 10.1016/j.ijbiomac.2020.07.180
|
| 407 |
Nitu Dogra, Ruchi Jakhmola Mani, Deepshikha Pande Katare. The Gut-Brain Axis: Two Ways Signaling in Parkinson’s Disease. Cellular and Molecular Neurobiology 2022; 42(2): 315 doi: 10.1007/s10571-021-01066-7
|
| 408 |
Ilaria Cova, Alberto Priori. Diagnostic biomarkers for Parkinson’s disease at a glance: where are we?. Journal of Neural Transmission 2018; 125(10): 1417 doi: 10.1007/s00702-018-1910-4
|
| 409 |
Manuele Biazzo, Manuela Allegra, Gabriele Deidda. Clostridioides difficile and neurological disorders: New perspectives. Frontiers in Neuroscience 2022; 16 doi: 10.3389/fnins.2022.946601
|
| 410 |
Arshilin Philip Mani, Balamuralikrishnan Balasubramanian, Linsha A. Mali, Kadanthottu Sebastian Joseph, Arun Meyyazhagan, Manikantan Pappuswamy, Biljo V. Joseph. The Role of the Gut Microbiota in Neurodegenerative Diseases. Microbiology Research 2024; 15(2): 489 doi: 10.3390/microbiolres15020033
|
| 411 |
Roberta J. Ward, David T. Dexter, Antonio Martin-Bastida, Robert R. Crichton. Is Chelation Therapy a Potential Treatment for Parkinson’s Disease?. International Journal of Molecular Sciences 2021; 22(7): 3338 doi: 10.3390/ijms22073338
|
| 412 |
Eamonn M. M. Quigley. What can we learn from other clinical settings on the influence of the gut microbiome on the brain?. Clinical Liver Disease 2017; 9(2): 52 doi: 10.1002/cld.614
|
| 413 |
|
| 414 |
Yogesh Singh, Christoph Trautwein, Achal Dhariwal, Madhuri S. Salker, Md Alauddin, Laimdota Zizmare, Lisann Pelzl, Martina Feger, Jakob Admard, Nicolas Casadei, Michael Föller, Vivek Pachauri, David S. Park, Tak W. Mak, Julia-Stefanie Frick, Diethelm Wallwiener, Sara Y. Brucker, Florian Lang, Olaf Riess. DJ-1 (Park7) affects the gut microbiome, metabolites and the development of innate lymphoid cells (ILCs). Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-72903-w
|
| 415 |
Aaron Lerner, Sandra Neidhöfer, Torsten Matthias. The Gut Microbiome Feelings of the Brain: A Perspective for Non-Microbiologists. Microorganisms 2017; 5(4): 66 doi: 10.3390/microorganisms5040066
|
| 416 |
Rosita Gabbianelli, Elisabetta Damiani. Epigenetics and neurodegeneration: role of early-life nutrition. The Journal of Nutritional Biochemistry 2018; 57: 1 doi: 10.1016/j.jnutbio.2018.01.014
|
| 417 |
Marthinus Janse van Vuuren, Theodore Albertus Nell, Jonathan Ambrose Carr, Douglas B. Kell, Etheresia Pretorius. Iron Dysregulation and Inflammagens Related to Oral and Gut Health Are Central to the Development of Parkinson’s Disease. Biomolecules 2020; 11(1): 30 doi: 10.3390/biom11010030
|
| 418 |
Ruixue Huang. Gut Microbiota: A Key Regulator in the Effects of Environmental Hazards on Modulates Insulin Resistance. Frontiers in Cellular and Infection Microbiology 2022; 11 doi: 10.3389/fcimb.2021.800432
|
| 419 |
Jessica Fessler, Vyara Matson, Thomas F. Gajewski. Exploring the emerging role of the microbiome in cancer immunotherapy. Journal for ImmunoTherapy of Cancer 2019; 7(1) doi: 10.1186/s40425-019-0574-4
|
| 420 |
Aeja Jackson, Christopher B. Forsyth, Maliha Shaikh, Robin M. Voigt, Phillip A. Engen, Vivian Ramirez, Ali Keshavarzian. Diet in Parkinson's Disease: Critical Role for the Microbiome. Frontiers in Neurology 2019; 10 doi: 10.3389/fneur.2019.01245
|
| 421 |
Qiaoyu Sun, Lu Cheng, Xiaoxiong Zeng, Xin Zhang, Zufang Wu, Peifang Weng. The modulatory effect of plant polysaccharides on gut flora and the implication for neurodegenerative diseases from the perspective of the microbiota-gut-brain axis. International Journal of Biological Macromolecules 2020; 164: 1484 doi: 10.1016/j.ijbiomac.2020.07.208
|
| 422 |
Jing Sun, Zongxin Ling, Fangyan Wang, Wenqian Chen, Haixiao Li, Jiangtao Jin, Huiqing Zhang, Mengqi Pang, Junjie Yu, Jiaming Liu. Clostridium butyricum pretreatment attenuates cerebral ischemia/reperfusion injury in mice via anti-oxidation and anti-apoptosis. Neuroscience Letters 2016; 613: 30 doi: 10.1016/j.neulet.2015.12.047
|
| 423 |
Liang Shen. Gut, oral and nasal microbiota and Parkinson’s disease. Microbial Cell Factories 2020; 19(1) doi: 10.1186/s12934-020-01313-4
|
| 424 |
Emily M. Klann, Upuli Dissanayake, Anjela Gurrala, Matthew Farrer, Aparna Wagle Shukla, Adolfo Ramirez-Zamora, Volker Mai, Vinata Vedam-Mai. The Gut–Brain Axis and Its Relation to Parkinson’s Disease: A Review. Frontiers in Aging Neuroscience 2022; 13 doi: 10.3389/fnagi.2021.782082
|
| 425 |
Xiao Wang, Min Wu. Research progress of gut microbiota and frailty syndrome. Open Medicine 2021; 16(1): 1525 doi: 10.1515/med-2021-0364
|
| 426 |
Myat Noe Han, David I. Finkelstein, Rachel M. McQuade, Shanti Diwakarla. Gastrointestinal Dysfunction in Parkinson’s Disease: Current and Potential Therapeutics. Journal of Personalized Medicine 2022; 12(2): 144 doi: 10.3390/jpm12020144
|
| 427 |
Jonathan Timpka, Per Odin. Autonomic Dysfunction in Parkinson's Disease. International Review of Movement Disorders 2021; 1: 179 doi: 10.1016/bs.irmvd.2021.07.004
|
| 428 |
Cassandra Francella, Jane A. Foster. Burger's Medicinal Chemistry and Drug Discovery. 2021; : 1 doi: 10.1002/0471266949.bmc297
|